<html class="gs_el_sm gs_pfcs"><head><title>‪A. T. Cohen‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=YtROf4UAAAAJ&amp;hl=en"><meta name="description" content="‪Consultant Vascular Physician, Guy's and St Thomas' Hospitals NHS Foundation Trust‬ - ‪‪Cited by 30,898‬‬ - ‪Cardiovascular Medicine‬"><meta property="og:description" content="‪Consultant Vascular Physician, Guy's and St Thomas' Hospitals NHS Foundation Trust‬ - ‪‪Cited by 30,898‬‬ - ‪Cardiovascular Medicine‬"><meta property="og:title" content="A. T. Cohen"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=YtROf4UAAAAJ&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"p9I9YZShHMi1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=YtROf4UAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8kJ6RNxZryg1laTChLBvhXttavRgvy"><input type="hidden" name="user" value="YtROf4UAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">30898</td><td class="gsc_rsb_std">14989</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">69</td><td class="gsc_rsb_std">53</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">210</td><td class="gsc_rsb_std">163</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:934px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:888px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">3200</div><div class="gsc_g_xtl" style="top:73px;">1600</div><div class="gsc_g_xtl" style="top:113px;">800</div><div class="gsc_g_xtl" style="top:33px;">2400</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:156px;height:4px;z-index:27"><span class="gsc_g_al">88</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:157px;height:3px;z-index:26"><span class="gsc_g_al">65</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:156px;height:4px;z-index:25"><span class="gsc_g_al">93</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:155px;height:5px;z-index:24"><span class="gsc_g_al">107</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:156px;height:4px;z-index:23"><span class="gsc_g_al">97</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:153px;height:7px;z-index:22"><span class="gsc_g_al">149</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:152px;height:8px;z-index:21"><span class="gsc_g_al">166</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:151px;height:9px;z-index:20"><span class="gsc_g_al">187</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:145px;height:15px;z-index:19"><span class="gsc_g_al">315</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:138px;height:22px;z-index:18"><span class="gsc_g_al">454</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:126px;height:34px;z-index:17"><span class="gsc_g_al">687</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:123px;height:37px;z-index:16"><span class="gsc_g_al">746</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:124px;height:36px;z-index:15"><span class="gsc_g_al">731</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:113px;height:47px;z-index:14"><span class="gsc_g_al">955</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:101px;height:59px;z-index:13"><span class="gsc_g_al">1197</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:99px;height:61px;z-index:12"><span class="gsc_g_al">1222</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:93px;height:67px;z-index:11"><span class="gsc_g_al">1345</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:92px;height:68px;z-index:10"><span class="gsc_g_al">1364</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:83px;height:77px;z-index:9"><span class="gsc_g_al">1546</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:76px;height:84px;z-index:8"><span class="gsc_g_al">1688</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:71px;height:89px;z-index:7"><span class="gsc_g_al">1799</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:54px;height:106px;z-index:6"><span class="gsc_g_al">2130</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:45px;height:115px;z-index:5"><span class="gsc_g_al">2305</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:31px;height:129px;z-index:4"><span class="gsc_g_al">2582</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:37px;height:123px;z-index:3"><span class="gsc_g_al">2474</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:5px;height:155px;z-index:2"><span class="gsc_g_al">3109</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:48px;height:112px;z-index:1"><span class="gsc_g_al">2245</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=YtROf4UAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dYtROf4UAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>20 articles</span></div><div class="gsc_rsb_m_na"><div>7 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:26%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:91px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:56pt;height:80pt;}}</style><img alt="A. T. Cohen" sizes="print 56px,91px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=YtROf4UAAAAJ&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=YtROf4UAAAAJ&amp;citpid=1 91w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=YtROf4UAAAAJ&amp;citpid=1 183w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">A. T. Cohen</div><div class="gsc_prf_il">Consultant Vascular Physician, Guy's and St Thomas' Hospitals NHS Foundation Trust</div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at KCL.AC.UK</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cardiovascular_medicine" class="gsc_prf_inta gs_ibl">Cardiovascular Medicine</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8kJ6RNxZryg1laTChLBvhXttavRgvy"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=YtROf4UAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Oral apixaban for the treatment of acute venous thromboembolism</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ...</div><div class="gs_gray">N engl j med 369, 799-808<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1659807039012294670" class="gsc_a_ac gs_ibl">2168</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:J-pR_7NvFogC" class="gsc_a_at">A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients</a><div class="gs_gray">MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ...</div><div class="gs_gray">New England Journal of Medicine 341 (11), 793-800<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5005698054536436403" class="gsc_a_ac gs_ibl">1963</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:mKu_rENv82IC" class="gsc_a_at">Venous thromboembolism (VTE) in Europe</a><div class="gs_gray">AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ...</div><div class="gs_gray">Thrombosis and haemostasis 98 (10), 756-764<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14634197520401821488" class="gsc_a_ac gs_ibl">1835</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study</a><div class="gs_gray">AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, AK Kakkar, ...</div><div class="gs_gray">The lancet 371 (9610), 387-394<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12961788189783211290" class="gsc_a_ac gs_ibl">1689</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Apixaban for extended treatment of venous thromboembolism</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ...</div><div class="gs_gray">N Engl J Med 368, 699-708<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18038888907044285345" class="gsc_a_ac gs_ibl">1310</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer</a><div class="gs_gray">D Bergqvist, G Agnelli, AT Cohen, A Eldor, PE Nilsson, ...</div><div class="gs_gray">New England Journal of Medicine 346 (13), 975-980<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7530806949895477998" class="gsc_a_ac gs_ibl">1220</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients</a><div class="gs_gray">A Leizorovicz, AT Cohen, AGG Turpie, CG Olsson, PT Vaitkus, ...</div><div class="gs_gray">Circulation 110 (7), 874-879<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8523627355942431904,8627792519338650681" class="gsc_a_ac gs_ibl">1103</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial</a><div class="gs_gray">AT Cohen, BL Davidson, AS Gallus, MR Lassen, MH Prins, W Tomkowski, ...</div><div class="gs_gray">Bmj 332 (7537), 325-329<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3059160113684599603" class="gsc_a_ac gs_ibl">954</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Andexanet alfa for acute major bleeding associated with factor Xa inhibitors</a><div class="gs_gray">SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...</div><div class="gs_gray">New England Journal of Medicine 375 (12), 1131-1141<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9763357136414204544" class="gsc_a_ac gs_ibl">770</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study</a><div class="gs_gray">R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...</div><div class="gs_gray">Archives of internal medicine 164 (9), 963-968<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1647274965027395862" class="gsc_a_ac gs_ibl">637</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Rivaroxaban for thromboprophylaxis in acutely ill medical patients</a><div class="gs_gray">AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...</div><div class="gs_gray">N engl j med 368, 513-523<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15303313413097873136" class="gsc_a_ac gs_ibl">609</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Rivaroxaban or aspirin for extended treatment of venous thromboembolism</a><div class="gs_gray">JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ...</div><div class="gs_gray">New England Journal of Medicine 376 (13), 1211-1222<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7671780223349401206" class="gsc_a_ac gs_ibl">554</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies</a><div class="gs_gray">MH Prins, AWA Lensing, R Bauersachs, B van Bellen, H Bounameaux, ...</div><div class="gs_gray">Thrombosis journal 11 (1), 1-10<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7221662961396854573" class="gsc_a_ac gs_ibl">553</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery</a><div class="gs_gray">VV Kakkar, AT Cohen, RA Edmonson, MJ Phillips, SK Das, KT Maher, ...</div><div class="gs_gray">The Lancet 341 (8840), 259-265<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5417927668777642253" class="gsc_a_ac gs_ibl">489</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors</a><div class="gs_gray">SJ Connolly, M Crowther, JW Eikelboom, CM Gibson, JT Curnutte, ...</div><div class="gs_gray">New England Journal of Medicine 380 (14), 1326-1335<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17272479324927488076" class="gsc_a_ac gs_ibl">430</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US.</a><div class="gs_gray">JA Heit, AT Cohen, FA Anderson Jr</div><div class="gs_gray">Blood 106 (11), 910<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4998090580392116921" class="gsc_a_ac gs_ibl">407</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Idraparinux versus standard therapy for venous thromboembolic disease</a><div class="gs_gray">van Gogh Investigators</div><div class="gs_gray">New England Journal of Medicine 357 (11), 1094-1104<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8873573129095814714,4469128309516650550" class="gsc_a_ac gs_ibl">395</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis&nbsp;…</a><div class="gs_gray">HR Buller, AWA Lensing, MH Prins, G Agnelli, A Cohen, AS Gallus, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (6), 2242-2247<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9371496431683280186" class="gsc_a_ac gs_ibl">388</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Extended thromboprophylaxis with betrixaban in acutely ill medical patients</a><div class="gs_gray">AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ...</div><div class="gs_gray">New England Journal of Medicine 375 (6), 534-544<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2331496381176604754" class="gsc_a_ac gs_ibl">383</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;citation_for_view=YtROf4UAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Randomized clinical trial of postoperative fondaparinux <i>versus</i> perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery</a><div class="gs_gray">G Agnelli, D Bergqvist, AT Cohen, AS Gallus, M Gent</div><div class="gs_gray">Journal of British Surgery 92 (10), 1212-1220<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17300670677340262545" class="gsc_a_ac gs_ibl">351</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Guidelines on the use and monitoring of heparin.</a><div class="gs_gray">T Baglin, TW Barrowcliffe, A Cohen, M Greaves, ...</div><div class="gs_gray">British journal of haematology 133 (1), 19-34<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1406870133971664024" class="gsc_a_ac gs_ibl">344</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement</a><div class="gs_gray">BI Eriksson, G Agnelli, AT Cohen, OE Dahl, P Mouret, N Rosencher, ...</div><div class="gs_gray">Thrombosis and haemostasis 89 (02), 288-296<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5009517494504274725" class="gsc_a_ac gs_ibl">333</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:8d8msizDQcsC" class="gsc_a_at">Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism</a><div class="gs_gray">FA Anderson Jr, M Zayaruzny, JA Heit, D Fidan, AT Cohen</div><div class="gs_gray">American journal of hematology 82 (9), 777-782<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9285496620578769953" class="gsc_a_ac gs_ibl">331</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients</a><div class="gs_gray">AT Cohen, R Alikhan, JI Arcelus, JF Bergmann, S Haas, GJ Merli, ...</div><div class="gs_gray">Thrombosis and haemostasis 94 (10), 750-759<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8014178296808814856" class="gsc_a_ac gs_ibl">322</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study</a><div class="gs_gray">R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...</div><div class="gs_gray">Blood Coagulation &amp; Fibrinolysis 14 (4), 341-346<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17244970546075928991" class="gsc_a_ac gs_ibl">318</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:35r97b3x0nAC" class="gsc_a_at">Fatal pulmonary embolism in hospitalised patients: a necropsy review</a><div class="gs_gray">R Alikhan, F Peters, R Wilmott, AT Cohen</div><div class="gs_gray">Journal of clinical pathology 57 (12), 1254-1257<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6754547812929124545" class="gsc_a_ac gs_ibl">305</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Apixaban for the treatment of venous thromboembolism associated with cancer</a><div class="gs_gray">G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ...</div><div class="gs_gray">New England Journal of Medicine 382 (17), 1599-1607<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16115683763801260153" class="gsc_a_ac gs_ibl">300</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement&nbsp;…</a><div class="gs_gray">BI Eriksson, G Agnelli, AT Cohen, OE Dahl, MR Lassen, P Mouret, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 1 (12), 2490-2496<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10116392502529948280" class="gsc_a_ac gs_ibl">259</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a&nbsp;…</a><div class="gs_gray">MH Prins, AWA Lensing, TA Brighton, RM Lyons, J Rehm, M Trajanovic, ...</div><div class="gs_gray">The Lancet Haematology 1 (1), e37-e46<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1993543672544073170" class="gsc_a_ac gs_ibl">254</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Cancer-associated venous thromboembolism: burden, mechanisms, and management</a><div class="gs_gray">C Ay, I Pabinger, AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 117 (02), 219-230<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14705995904266022325" class="gsc_a_ac gs_ibl">241</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:OTTXONDVkokC" class="gsc_a_at">ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin along among 41 299 cases of suspected&nbsp;…</a><div class="gs_gray">D Hunt, J Varigos, F Dienstl, P Lechleitner, G De Backer, M KORNITZER, ...</div><div class="gs_gray">Lancet 339 (8796), 753-770<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9863898113070031068" class="gsc_a_ac gs_ibl">234</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Economic burden of long‐term complications of deep vein thrombosis after total hip replacement surgery in the United States</a><div class="gs_gray">JA Caprini, MF Botteman, JM Stephens, V Nadipelli, MM Ewing, S Brandt, ...</div><div class="gs_gray">Value in Health 6 (1), 59-74<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5002411642580932214" class="gsc_a_ac gs_ibl">198</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study</a><div class="gs_gray">A Leizorovicz, AGG Turpie, AT Cohen, L Wong, MC Yoo, A Dans, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 3 (1), 28-34<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15086575732631619225" class="gsc_a_ac gs_ibl">185</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial</a><div class="gs_gray">SK Das, AT Cohen, RA Edmondson, E Melissari, VV Kakkar</div><div class="gs_gray">World journal of surgery 20 (5), 521-527<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2638679157101702169" class="gsc_a_ac gs_ibl">184</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients</a><div class="gs_gray">PT Vaitkus, A Leizorovicz, AT Cohen, AGG Turpie, CG Olsson, ...</div><div class="gs_gray">Thrombosis and haemostasis 93 (01), 76-79<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6140127207951430985" class="gsc_a_ac gs_ibl">180</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer</a><div class="gs_gray">C Martinez, AT Cohen, L Bamber, S Rietbrock</div><div class="gs_gray">Thrombosis and haemostasis 112 (08), 255-263<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7045694335430020832" class="gsc_a_ac gs_ibl">179</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, AS Gallus, TC Lee, R Pak, GE Raskob, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13 (12), 2187-2191<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1625587641282458020" class="gsc_a_ac gs_ibl">173</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement</a><div class="gs_gray">G Raskob, AT Cohen, BI Eriksson, D Puskas, M Shi, T Bocanegra, ...</div><div class="gs_gray">Thrombosis and haemostasis 104 (09), 642-649<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14178295243725405900" class="gsc_a_ac gs_ibl">152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial</a><div class="gs_gray">VV Kakkar, O Boeckl, B Boneu, L Bordenave, OA Brehm, P Brücke, ...</div><div class="gs_gray">World journal of surgery 21 (1), 2-9<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2051368642333533044" class="gsc_a_ac gs_ibl">152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Extended prophylaxis of venous thromboembolism with idraparinux</a><div class="gs_gray">van Gogh Investigators</div><div class="gs_gray">New England Journal of Medicine 357 (11), 1105-1112<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14963896023553369305,13976176882795533219" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism&nbsp;…</a><div class="gs_gray">AT Cohen, M Hamilton, SA Mitchell, H Phatak, X Liu, A Bird, D Tushabe, ...</div><div class="gs_gray">PloS one 10 (12), e0144856<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7511661823523644538" class="gsc_a_ac gs_ibl">146</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">The changing pattern of venous thromboembolic disease</a><div class="gs_gray">AT Cohen, RA Edmondson, MJ Phillips, VP Ward, VV Kakkar</div><div class="gs_gray">Pathophysiology of Haemostasis and Thrombosis 26 (2), 65-71<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1962330311915042640" class="gsc_a_ac gs_ibl">146</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis</a><div class="gs_gray">GH Lyman, L Eckert, Y Wang, H Wang, A Cohen</div><div class="gs_gray">The oncologist 18 (12), 1321<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16996664886410030772" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use</a><div class="gs_gray">I Martinelli, AWA Lensing, S Middeldorp, M Levi, J Beyer-Westendorf, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 127 (11), 1417-1425<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3319046471898117311" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol</a><div class="gs_gray">AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 31 (4), 407-416<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9959438382371593256" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">AHA statistical update</a><div class="gs_gray">AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...</div><div class="gs_gray">Circulation 127, e62-e245<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6162116165863662963" class="gsc_a_ac gs_ibl">139</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:FAceZFleit8C" class="gsc_a_at">Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial</a><div class="gs_gray">N Kucher, A Leizorovicz, PT Vaitkus, AT Cohen, AGG Turpie, CG Olsson, ...</div><div class="gs_gray">Archives of internal medicine 165 (3), 341-345<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9285449954098225286" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting</a><div class="gs_gray">RA Edmondson, AT Cohen, SK Das, MB Wagner, VV Kakkar</div><div class="gs_gray">The Lancet 344 (8927), 914-918<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3760262384580982302,13240105889380800844" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Epidemiology of first and recurrent venous thromboembolism in patients with active cancer</a><div class="gs_gray">AT Cohen, A Katholing, S Rietbrock, L Bamber, C Martinez</div><div class="gs_gray">Thrombosis and haemostasis 26 (01), 57-65<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13759830564460884494" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Long‐haul flights and deep vein thrombosis: a significant risk only when additional factors are also present</a><div class="gs_gray">R Arya, JA Barnes, U Hossain, RK Patel, AT Cohen</div><div class="gs_gray">British Journal of Haematology 116 (3), 653-654<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1090747970029115388" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:xm0LlTxljI0C" class="gsc_a_at">VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality</a><div class="gs_gray">AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ...</div><div class="gs_gray">Thromb Haemost 98 (4), 756-764<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16421529404755287730" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty-a meta-analysis</a><div class="gs_gray">AT Cohen, CS Bailey, R Alikhan, DJ Cooper</div><div class="gs_gray">Thrombosis and haemostasis 85 (05), 940-941<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12096025204376160087" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients</a><div class="gs_gray">AK Kakkar, AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, ...</div><div class="gs_gray">Annals of surgery 251 (2), 330-338<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7543399375556465700" class="gsc_a_ac gs_ibl">124</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients</a><div class="gs_gray">JF Bergmann, AT Cohen, VF Tapson, SZ Goldhaber, AK Kakkar, ...</div><div class="gs_gray">Thrombosis and haemostasis 103 (04), 736-748<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3356043151079411960" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:08ZZubdj9fEC" class="gsc_a_at">ENDORSE Investigators: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study</a><div class="gs_gray">AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, AK Kakkar, ...</div><div class="gs_gray">Lancet 371 (9610), 387-394<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4414695798394825354" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Testosterone treatment and risk of venous thromboembolism: population based case-control study</a><div class="gs_gray">C Martinez, S Suissa, S Rietbrock, A Katholing, B Freedman, AT Cohen, ...</div><div class="gs_gray">Bmj 355<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14579812591477208246" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran</a><div class="gs_gray">G Agnelli, BI Eriksson, AT Cohen, D Bergqvist, OE Dahl, MR Lassen, ...</div><div class="gs_gray">Thrombosis research 123 (3), 488-497<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=493738237468967024" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Liver transplantation after paracetamol overdose.</a><div class="gs_gray">JG O'Grady, J Wendon, KC Tan, D Potter, S Cottam, AT Cohen, ...</div><div class="gs_gray">British Medical Journal 303 (6796), 221-223<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13677218119979273030" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial</a><div class="gs_gray">AT Cohen, TE Spiro, AC Spyropoulos, YH Desanctis, M Homering, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 12 (4), 479-487<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10691962815771289518" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:tzM49s52ZIMC" class="gsc_a_at">PREVENT Medical Thromboprophylaxis Study Group: Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients</a><div class="gs_gray">A Leizorovicz, AT Cohen, AG Turpie, CG Olsson, PT Vaitkus, ...</div><div class="gs_gray">Circulation 110 (7), 874-879<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6677883726301995431" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)</a><div class="gs_gray">R Alikhan, AT Cohen</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3099655968595293083" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)</a><div class="gs_gray">R Alikhan, R Forster, AT Cohen</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7070866063617392141" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:LhH-TYMQEocC" class="gsc_a_at">The design and rationale for the acute medically ill venous thromboembolism prevention with extended duration betrixaban (APEX) study</a><div class="gs_gray">AT Cohen, R Harrington, SZ Goldhaber, R Hull, CM Gibson, ...</div><div class="gs_gray">American heart journal 167 (3), 335-341<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10619209715954046804" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:mUJArPsKIAAC" class="gsc_a_at">Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: the Caravaggio study</a><div class="gs_gray">G Agnelli, C Becattini, R Bauersachs, B Brenner, M Campanini, A Cohen, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (09), 1668-1678<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15116826810347210272" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">Thrombosis in inflammatory bowel diseases: what’s the link?</a><div class="gs_gray">M Giannotta, G Tapete, G Emmi, E Silvestri, M Milla</div><div class="gs_gray">Thrombosis Journal 13 (1), 1-9<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12060894597910673071,8402836474306383827" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database</a><div class="gs_gray">S Barco, SH Mahmoudpour, L Valerio, FA Klok, T Münzel, S Middeldorp, ...</div><div class="gs_gray">The Lancet Respiratory Medicine 8 (3), 277-287<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5605371982141973287" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Why do we need observational studies of everyday patients in the real-life setting?</a><div class="gs_gray">AT Cohen, S Goto, K Schreiber, C Torp-Pedersen</div><div class="gs_gray">European Heart Journal Supplements 17 (suppl_D), D2-D8<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17968331170157856080" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:IWHjjKOFINEC" class="gsc_a_at">ARTEMIS Investigators: Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial</a><div class="gs_gray">AT Cohen, BL Davidson, AS Gallus, MR Lassen, MH Prins, W Tomkowski, ...</div><div class="gs_gray">BMJ 332 (7537), 325-329<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1705862092803789731" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:UuEBAcK4md4C" class="gsc_a_at">The IMPROVEDD VTE risk score: incorporation of D-Dimer into the IMPROVE score to improve venous thromboembolism risk stratification</a><div class="gs_gray">CM Gibson, AC Spyropoulos, AT Cohen, RD Hull, SZ Goldhaber, ...</div><div class="gs_gray">TH open 1 (01), e56-e65<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16339864354111781215" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:WC23djZS0W4C" class="gsc_a_at">The use of graduated compression stockings in association with fondaparinux in surgery of the hip: a multicentre, multinational, randomised, open-label, parallel-group&nbsp;…</a><div class="gs_gray">AT Cohen, JA Skinner, D Warwick, I Brenkel</div><div class="gs_gray">The Journal of bone and joint surgery. British volume 89 (7), 887-892<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13271277143775069008" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:LI9QrySNdTsC" class="gsc_a_at">The management of acute venous thromboembolism in clinical practice</a><div class="gs_gray">AT Cohen, AK Gitt, R Bauersachs, EM Fronk, P Laeis, P Mismetti, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (07), 1326-1337<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8033932741101581263" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:35N4QoGY0k4C" class="gsc_a_at">D-Dimer elevation and adverse outcomes</a><div class="gs_gray">R Halaby, CJ Popma, A Cohen, G Chi, MR Zacarkim, G Romero, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 39 (1), 55-59<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2691399132408725508" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and&nbsp;…</a><div class="gs_gray">MF Botteman, J Caprini, JM Stephens, V Nadipelli, CF Bell, CL Pashos, ...</div><div class="gs_gray">Clinical therapeutics 24 (11), 1960-1986<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=897992888383586154" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (ARTEMIS)</a><div class="gs_gray">AT Cohen, AS Gallus, MR Lassen, W Tomkowski, AGG Turpie, ...</div><div class="gs_gray">J Thromb Haemost 1 (suppl 1), P2046<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12661287826587297738" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity DVT: systematic review and meta-analysis</a><div class="gs_gray">C Becattini, AT Cohen, G Agnelli, L Howard, B Castejón, J Trujillo-Santos, ...</div><div class="gs_gray">Chest 149 (1), 192-200<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12921064433799323338" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism</a><div class="gs_gray">JI Weitz, R Bauersachs, J Beyer-Westendorf, H Bounameaux, TA Brighton, ...</div><div class="gs_gray">Thrombosis and Haemostasis 114 (09), 645-650<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10011618878985057785" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study</a><div class="gs_gray">G Raskob, W Ageno, AT Cohen, MPA Brekelmans, MA Grosso, A Segers, ...</div><div class="gs_gray">The Lancet Haematology 3 (5), e228-e236<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4929737208341984608" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (Acute Medically Ill&nbsp;…</a><div class="gs_gray">CM Gibson, G Chi, R Halaby, S Korjian, Y Daaboul, P Jain, D Arbetter, ...</div><div class="gs_gray">Circulation 135 (7), 648-655<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14367979689376426087" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:738O_yMBCRsC" class="gsc_a_at">Thromboprophylaxis with dalteparin in medical patients: which patients benefit?</a><div class="gs_gray">AT Cohen, AGG Turpie, A Leizorovicz, CG Olsson, PT Vaitkus, ...</div><div class="gs_gray">Vascular Medicine 12 (2), 123-127<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4272523257531844487" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Fondaparinux for the prevention of VTE in acutely ill medical patients.</a><div class="gs_gray">AT Cohen, BL Davidson, AS Gallus, MR Lassen, W Tomkowski, ...</div><div class="gs_gray">Blood 102 (11), 15A-15A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11475894297731961379" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial</a><div class="gs_gray">CM Gibson, R Halaby, S Korjian, Y Daaboul, DF Arbetter, MK Yee, ...</div><div class="gs_gray">American heart journal 185, 93-100<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2963468896868017168" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Comparison of the non-VKA oral anticoagulants apixaban, dabigatran, and rivaroxaban in the extended treatment and prevention of venous thromboembolism: systematic review and&nbsp;…</a><div class="gs_gray">AT Cohen, M Hamilton, A Bird, SA Mitchell, S Li, R Horblyuk, S Batson</div><div class="gs_gray">PLoS One 11 (8), e0160064<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4225760192656081540" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Treatment of venous thromboembolism with rivaroxaban in relation to body weight</a><div class="gs_gray">M Di Nisio, MC Vedovati, A Riera-Mestre, MH Prins, K Mueller, AT Cohen, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (10), 739-746<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14176900580926840265" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?</a><div class="gs_gray">AT Cohen, JA Skinner, VV Kakkar</div><div class="gs_gray">BMJ 309 (6963), 1213-1215<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9637713995056254118" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Prophylaxis in Medical Patients with Enoxaparin Study Group A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients</a><div class="gs_gray">MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ...</div><div class="gs_gray">N Engl J Med 341 (11), 793-800<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6463927847468128878" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:uWiczbcajpAC" class="gsc_a_at">Risk of recurrent venous thromboembolism according to baseline risk factor profiles</a><div class="gs_gray">MH Prins, AWA Lensing, P Prandoni, PS Wells, P Verhamme, ...</div><div class="gs_gray">Blood advances 2 (7), 788-796<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7396101197356547535" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Thromboembolic prevention in frail elderly patients with atrial fibrillation: a practical algorithm</a><div class="gs_gray">S Granziera, AT Cohen, G Nante, E Manzato, G Sergi</div><div class="gs_gray">Journal of the American Medical Directors Association 16 (5), 358-364<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17200822881938538656" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:KUbvn5osdkgC" class="gsc_a_at">The use of rivaroxaban for short-and long-term treatment of venous thromboembolism</a><div class="gs_gray">AT Cohen, M Dobromirski</div><div class="gs_gray">Thrombosis and haemostasis 107 (06), 1035-1043<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7705934519175191354" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Tranexamic acid reduces blood loss after knee arthroplasty</a><div class="gs_gray">JP Howes, V Sharma, AT Cohen</div><div class="gs_gray">The Journal of bone and joint surgery. British volume 78 (6), 995-996<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=477272005890082045" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Prospective study of the quality of life in patients assessed for liver transplantation: outcome in transplanted and not transplanted groups.</a><div class="gs_gray">CE Price, D Lowe, AT Cohen, FD Reid, GM Forbes, J McEwen, R Williams</div><div class="gs_gray">Journal of the Royal Society of Medicine 88 (3), 130<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12568580203756753643" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:KaMxkj08jr0C" class="gsc_a_at">Predicting the risk of venous thromboembolism in patients hospitalized with heart failure</a><div class="gs_gray">A Mebazaa, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, G Merli, ...</div><div class="gs_gray">Circulation 130 (5), 410-418<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14082590263843774411" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis</a><div class="gs_gray">AT Cohen, MB Wagner, MS Mohamed</div><div class="gs_gray">The American journal of surgery 174 (1), 1-5<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3279690965947016650" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013</a><div class="gs_gray">C Martinez, A Katholing, C Wallenhorst, S Granziera, AT Cohen, ...</div><div class="gs_gray">Heart 101 (21), 1748-1754<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6158908572967991610" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:eflP2zaiRacC" class="gsc_a_at">The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis</a><div class="gs_gray">A Cohen, P Drost, N Marchant, S Mitchell, M Orme, D Rublee, TA Simon, ...</div><div class="gs_gray">Clinical and Applied Thrombosis/Hemostasis 18 (6), 611-627<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4857595090328207188" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">A safety analysis of thromboprophylaxis in acute medical illness</a><div class="gs_gray">R Alikhan, AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 89 (03), 590-591<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12639407460357622331" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Risk factors for venous thromboembolism in orthopedic surgery.</a><div class="gs_gray">HM Zaw, IC Osborne, PN Pettit, AT Cohen</div><div class="gs_gray">The Israel Medical Association Journal: IMAJ 4 (11), 1040-1042<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10356287373041935909" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study</a><div class="gs_gray">R Sallie, AT Cohen, CJ Tibbs, BC Portmann, A Rayner, JG O'Grady, ...</div><div class="gs_gray">Journal of hepatology 21 (4), 536-542<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4303564296973066656" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:UxriW0iASnsC" class="gsc_a_at">Managing pulmonary embolism from presentation to extended treatment</a><div class="gs_gray">AT Cohen, M Dobromirski, MMP Gurwith</div><div class="gs_gray">Thrombosis research 133 (2), 139-148<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3990256717640678268" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study</a><div class="gs_gray">L Desjardins, L Bara, F Boutitie, M Michel Samama, AT Cohen, S Combe, ...</div><div class="gs_gray">Archives of pathology &amp; laboratory medicine 128 (5), 519-526<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=461605858756215772" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=YtROf4UAAAAJ:UmS_249rOGwC" class="gsc_a_at">The management of acute venous thromboembolism in clinical practice–study rationale and protocol of the European PREFER in VTE Registry</a><div class="gs_gray">G Agnelli, AK Gitt, R Bauersachs, EM Fronk, P Laeis, P Mismetti, ...</div><div class="gs_gray">Thrombosis journal 13 (1), 1-13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16786958905533971480" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">The oral direct thrombin inhibitor ximelagatran, and its subcutaneous (sc) form melagatran, compared with enoxaparin for prophylaxis of venous thromboembolism (VTE) in total&nbsp;…</a><div class="gs_gray">BI Eriksson, G Agnelli, AT Cohen, OE Dahl, MR Lassen, P Mouret, ...</div><div class="gs_gray">Blood 100 (11), 82A-82A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8559486687296946466" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults</a><div class="gs_gray">AT Cohen, JG O'Grady, S Sutherland, R Sallie, KC Tan, R Williams</div><div class="gs_gray">Journal of medical virology 40 (1), 5-9<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8176723469154441522" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HE397vMXCloC" class="gsc_a_at">VTE prophylaxis for the medical patient: where do we stand?–a focus on cancer patients</a><div class="gs_gray">AT Cohen, B Nandini, JO Wills, S Ota</div><div class="gs_gray">Thrombosis research 125, S21-S29<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5170605830312681594" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Zph67rFs4hoC" class="gsc_a_at">A randomized double-blind study to compare the efficacy and safety of postoperative fondaparinux (Arixtra (R)) and preoperative dalteparin in the prevention of venous&nbsp;…</a><div class="gs_gray">G Agnelli, D Bergqvist, A Cohen, AS Gallus, M Gent</div><div class="gs_gray">Blood 102 (11), 15A-15A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1255571718857827891" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis</a><div class="gs_gray">N Veronese, G Bano, G Bertozzo, S Granziera, M Solmi, E Manzato, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13 (9), 1665-1675<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=24478836408917586" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: comparison and critique of study methodology and results</a><div class="gs_gray">AT Cohen, S Imfeld, T Rider</div><div class="gs_gray">Advances in therapy 31 (5), 473-493<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14977347419467465618" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:u-coK7KVo8oC" class="gsc_a_at">VTE Impact Assessment Group</a><div class="gs_gray">JA Heit, AT Cohen, FA Anderson</div><div class="gs_gray">Estimated annual number of incident and recurrent, non-fatal and fatal&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11012666101996857087" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Prophylaxis of venous thromboembolism in medical patients</a><div class="gs_gray">AT Cohen, R Alikhan</div><div class="gs_gray">Current opinion in pulmonary medicine 7 (5), 332-337<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16887651601313296427" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Aul-kAQHnToC" class="gsc_a_at">PEP trial</a><div class="gs_gray">A Cohen, D Quinlan</div><div class="gs_gray">The Lancet 356 (9225), 247<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11001179637288981130" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Predicting atrial fibrillation in primary care using machine learning</a><div class="gs_gray">NR Hill, D Ayoubkhani, P McEwan, DM Sugrue, U Farooqui, S Lister, ...</div><div class="gs_gray">PloS one 14 (11), e0224582<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13847602675785365939" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Two year outcome after chronic iliac vein occlusion recanalisation using the Vici Venous Stent®</a><div class="gs_gray">S Black, A Gwozdz, N Karunanithy, J Silickas, K Breen, B Hunt, A Smith, ...</div><div class="gs_gray">European Journal of Vascular and Endovascular Surgery 56 (5), 710-718<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6825608567707791194" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism</a><div class="gs_gray">P Verhamme, PS Wells, A Segers, W Ageno, MPA Brekelmans, AT Cohen, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (10), 747-753<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6540128066502300577" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eGYfIraVYiQC" class="gsc_a_at">Venous thromboembolic disease management of the nonsurgical moderate-and high-risk patient</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Seminars in hematology 37, 19-22<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17406443139878292272" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qwy9JoKyICEC" class="gsc_a_at">How I manage venous thromboembolism risk in hospitalized medical patients</a><div class="gs_gray">M Dobromirski, AT Cohen</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (8), 1562-1569<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17184097661313576323" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Improving practices in US hospitals to prevent venous thromboembolism: lessons from ENDORSE</a><div class="gs_gray">FA Anderson Jr, SZ Goldhaber, VF Tapson, JF Bergmann, AK Kakkar, ...</div><div class="gs_gray">The American journal of medicine 123 (12), 1099-1106. e8<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4715723233656555466" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association</a><div class="gs_gray">EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ...</div><div class="gs_gray">Circulation 137 (12), e67-e492<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17347205870285292278" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Comparison of fatal or irreversible events with extended‐duration betrixaban versus standard dose enoxaparin in acutely ill medical patients: an APEX trial substudy</a><div class="gs_gray">CM Gibson, S Korjian, G Chi, Y Daaboul, P Jain, D Arbetter, ...</div><div class="gs_gray">Journal of the American Heart Association 6 (7), e006015<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5962934996441020663" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Long-term anticoagulation with rivaroxaban for preventing recurrent VTE: a benefit-risk analysis of EINSTEIN-extension</a><div class="gs_gray">PS Wells, MH Prins, B Levitan, J Beyer-Westendorf, TA Brighton, ...</div><div class="gs_gray">Chest 150 (5), 1059-1068<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5425545505554969929" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders</a><div class="gs_gray">AT Cohen, S Imfeld, J Markham, S Granziera</div><div class="gs_gray">Thrombosis research 135 (2), 217-225<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2657484871547539554" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial</a><div class="gs_gray">AT Cohen, HM Zaw, R Alikhan</div><div class="gs_gray">Seminars in hematology 38, 31-38<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3818228228223950198" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:rmuvC79q63oC" class="gsc_a_at">Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the&nbsp;…</a><div class="gs_gray">G Chi, MK Yee, AN Amin, SZ Goldhaber, AF Hernandez, RD Hull, ...</div><div class="gs_gray">Circulation 137 (1), 91-94<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8952999668963320939" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:anf4URPfarAC" class="gsc_a_at">Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 104 (11), 919-930<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9334216394820501345" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery</a><div class="gs_gray">AT Cohen, C Hirst, B Sherrill, P Holmes, D Fidan</div><div class="gs_gray">Journal of British Surgery 92 (11), 1335-1344<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4464845162361813483" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists</a><div class="gs_gray">SM Bleker, MPA Brekelmans, ES Eerenberg, AT Cohen, S Middeldorp, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (10), 1944-1951<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10047833464739179468" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Declining long-term risk of adverse events after first-time community-presenting venous thromboembolism: the population-based Worcester VTE Study (1999 to 2009)</a><div class="gs_gray">W Huang, RJ Goldberg, AT Cohen, FA Anderson, CI Kiefe, JM Gore, ...</div><div class="gs_gray">Thrombosis research 135 (6), 1100-1106<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3087129619907701909" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism</a><div class="gs_gray">D Barrios, R Morillo, I Guerassimova, E Barbero, H Escobar-Morreale, ...</div><div class="gs_gray">PLoS One 12 (11), e0187648<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1739986409285724" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Apixaban reduces hospitalizations in patients with venous thromboembolism: an analysis of the apixaban for the initial management of pulmonary embolism and deep‐vein thrombosis&nbsp;…</a><div class="gs_gray">X Liu, M Johnson, J Mardekian, H Phatak, J Thompson, AT Cohen</div><div class="gs_gray">Journal of the American Heart Association 4 (12), e002340<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9767788483157072330" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty</a><div class="gs_gray">AT Cohen, MJ Phillips, RA Edmondson, JA Skinner, SK Das, DJ Cooper, ...</div><div class="gs_gray">Thrombosis and haemostasis 72 (12), 793-798<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16261288156783761186" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hMod-77fHWUC" class="gsc_a_at">A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low&nbsp;…</a><div class="gs_gray">SI Noble, A Nelson, D Fitzmaurice, MJ Bekkers, J Baillie, S Sivell, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 19 (83), vii<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2280906670568942384" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Asymptomatic deep vein thrombosis is associated with an increased risk of death: insights from the APEX trial</a><div class="gs_gray">A Kalayci, CM Gibson, G Chi, MK Yee, S Korjian, S Datta, T Nafee, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (12), 2046-2052<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15026323387457904338" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: a comparison of efficacy and safety following treatment with direct oral&nbsp;…</a><div class="gs_gray">AT Cohen, NR Hill, X Luo, C Masseria, SA Abariga, AO Ashaye</div><div class="gs_gray">International journal of cardiology 269, 174-181<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18193994195754737322" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists</a><div class="gs_gray">M Di Nisio, G Raskob, HR Büller, MA Grosso, G Zhang, SM Winters, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (04), 784-793<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2928524266064124498" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study</a><div class="gs_gray">MPA Brekelmans, W Ageno, LF Beenen, B Brenner, HR Buller, CZ Chen, ...</div><div class="gs_gray">The Lancet Haematology 3 (9), e437-e445<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1958614591622294061" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:k_IJM867U9cC" class="gsc_a_at">Apixaban for the treatment of venous thromboembolism in cancer patients: data from the AMPLIFY trial</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, R Pak, GE Raskob, ...</div><div class="gs_gray">Canadian Journal of Cardiology 30 (10), S278<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2060223514637484348" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the US.(Poster# 68-I)</a><div class="gs_gray">JA Heit, AT Cohen, FA Anderson</div><div class="gs_gray">BLOOD-NEW YORK- 106 (11), 910<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10987282823828411057" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Epidemiology of post-operative venous thromboembolismin asian countries</a><div class="gs_gray">A Leizorovicz, AGG Turpie, AT Cohen, KS Dhillon, P Angchaisuksiri, ...</div><div class="gs_gray">International Journal of Angiology 13 (03), 101-108<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8529835659533566817" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015</a><div class="gs_gray">V Sundaram, C Bloom, R Zakeri, J Halcox, A Cohen, K Bowrin, JB Briere, ...</div><div class="gs_gray">European heart journal 41 (17), 1636-1649<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12592253244046337122" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Effectiveness and safety of apixaban versus warfarin as outpatient treatment of venous thromboembolism in US clinical practice</a><div class="gs_gray">D Weycker, X Li, GDV Wygant, T Lee, M Hamilton, X Luo, L Vo, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (11), 1951-1961<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13825646883639534953" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Case report: central venous catheter fracture due to compression between the clavicle and first rib.</a><div class="gs_gray">WH Ramsden, AT Cohen, KS Blanshard</div><div class="gs_gray">Clinical radiology 50 (1), 59-60<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9413501447207403557" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:X0DADzN9RKwC" class="gsc_a_at">Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database</a><div class="gs_gray">S Barco, L Valerio, W Ageno, AT Cohen, SZ Goldhaber, BJ Hunt, A Iorio, ...</div><div class="gs_gray">The Lancet Respiratory Medicine 9 (1), 33-42<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3652806043174185502" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?</a><div class="gs_gray">AT Cohen, A Khushal</div><div class="gs_gray">Pathophysiology of Haemostasis and Thrombosis 30 (Suppl. 2), 88-94<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2455330638294160766" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Prevention of perioperative myocardial ischaemia and its complications.</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Lancet (London, England) 351 (9100), 385-386<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16340007282586742386" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ndLnGcHYRF0C" class="gsc_a_at">Diagnosis and management of heparin-induced thrombocytopenia</a><div class="gs_gray">Y Gruel, E De Maistre, C Pouplard, F Mullier, S Susen, S Roullet, N Blais, ...</div><div class="gs_gray">Anaesthesia Critical Care &amp; Pain Medicine 39 (2), 291-310<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16813407650593765444" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England</a><div class="gs_gray">C Martinez, C Wallenhorst, S Teal, AT Cohen, AJ Peacock</div><div class="gs_gray">Pulmonary circulation 8 (3), 2045894018791358<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4623176889220491825" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial</a><div class="gs_gray">FF Van Doormaal, AT Cohen, BL Davidson, H Decousus, AS Gallus, ...</div><div class="gs_gray">Thrombosis and haemostasis 104 (07), 86-91<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18398260788706500899" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial</a><div class="gs_gray">G Chi, CM Gibson, Y Liu, AF Hernandez, RD Hull, AT Cohen, ...</div><div class="gs_gray">American journal of hematology 94 (1), 21-28<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12662822111914614547" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Association of anemia with venous thromboembolism in acutely ill hospitalized patients: an APEX trial substudy</a><div class="gs_gray">G Chi, CM Gibson, AF Hernandez, RD Hull, SHA Kazmi, A Younes, ...</div><div class="gs_gray">The American journal of medicine 131 (8), 972. e1-972. e7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=700361253680288624" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Thrombus burden of deep vein thrombosis and its association with thromboprophylaxis and D-dimer measurement: insights from the APEX trial</a><div class="gs_gray">G Chi, SZ Goldhaber, RD Hull, AF Hernandez, M Kerneis, F Al Khalfan, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (12), 2389-2395<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6915345927197636424" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">New antithrombotics in the prevention of thromboembolic disease</a><div class="gs_gray">YY Yavin, M Wolozinsky, AT Cohen</div><div class="gs_gray">European journal of internal medicine 16 (4), 257-266<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14711617609230079367" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Postoperative melagatran/ximelagatran for the Prevention of venous thromboembolism following Major Elective Orthopaedic Surgery</a><div class="gs_gray">OE Dahl, BI Eriksson, G Agnelli, AT Cohen, P Mouret, N Rosencher, ...</div><div class="gs_gray">Clinical drug investigation 25 (1), 65-77<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11951485227469252160" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KS-xo-ZNxMsC" class="gsc_a_at">Impact of high-dose prophylactic anticoagulation in critically ill patients with coronavirus disease 2019 pneumonia</a><div class="gs_gray">C Tacquard, A Mansour, A Godon, J Godet, J Poissy, D Garrigue, E Kipnis, ...</div><div class="gs_gray">Chest<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12420461122265936102" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis</a><div class="gs_gray">G Chi, SZ Goldhaber, JM Kittelson, AGG Turpie, AF Hernandez, RD Hull, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 15 (10), 1913-1922<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3907864130000934237" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France</a><div class="gs_gray">JF Bergmann, C Lloret-Linares, A Rami, AT Cohen, RP Garay, AK Kakkar, ...</div><div class="gs_gray">Presse Medicale (Paris, France: 1983) 40 (12 Pt 1), e528-37<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7279151195680265090" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:L1USKYWJimsC" class="gsc_a_at">An Adaptive-Design Dose-Ranging Study of PD 0348292, a New Oral Factor Xa Inhibitor, for Thromboprophylaxis after Total Knee Replacement Surgery.</a><div class="gs_gray">AT Cohen, D Armstrong, T Gazdzik, C Ryge, R Pak, J Mandema, R Boyd, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 980-980<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13420752196728640698" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:m92CDrhVnKEC" class="gsc_a_at">A risk assessment model for identifying medical patients who should receive thromboprophylaxis</a><div class="gs_gray">A Cohen, R Alikhan, J Arcelus, JF Bergmann, S Hass, G Merli</div><div class="gs_gray">J Thromb Haemost 1 (Supp), OC437<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10736029143806366525" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case–control study</a><div class="gs_gray">C Martinez, A Katholing, K Folkerts, AT Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14 (7), 1374-1383<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8549336556295893386" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HGTzPopzzJcC" class="gsc_a_at">Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy</a><div class="gs_gray">GE Raskob, AS Gallus, P Sanders, JR Thompson, G Agnelli, HR Buller, ...</div><div class="gs_gray">Thrombosis and haemostasis 115 (04), 809-816<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14359774816988990794" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5ugPr518TE4C" class="gsc_a_at">Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin</a><div class="gs_gray">SM Bleker, AT Cohen, HR Büller, G Agnelli, AS Gallus, GE Raskob, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (12), 1159-1164<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5010141176517448320" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients</a><div class="gs_gray">CM Gibson, T Nafee, MK Yee, G Chi, S Korjian, Y Daaboul, F AlKhalfan, ...</div><div class="gs_gray">American heart journal 198, 84-90<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11529524554690242634" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study</a><div class="gs_gray">W Huang, RJ Goldberg, FA Anderson, AT Cohen, FA Spencer</div><div class="gs_gray">Journal of thrombosis and thrombolysis 41 (3), 525-538<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14796961308951935194" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Managing venous thromboembolism in Asia: winds of change in the era of new oral anticoagulants</a><div class="gs_gray">A Cohen, KM Chiu, K Park, S Jeyaindran, KL Tambunan, C Ward, ...</div><div class="gs_gray">Thrombosis research 130 (3), 291-301<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4913660219930659843" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Long-term benefits of preventing venous thromboembolic events</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Current medical research and opinion 28 (6), 877-889<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15892119300803582830" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Thromboprophylaxis in major abdominal surgery for cancer</a><div class="gs_gray">JJ Negus, JJ Gardner, O Tann, S Lewis, AT Cohen</div><div class="gs_gray">European Journal of Surgical Oncology (EJSO) 32 (9), 911-916<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2145145271537114672" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Thromboembolic disease in surgery for malignancy-rationale for prolonged thromboprophylaxis</a><div class="gs_gray">A Khushal, D Quinlan, R Alikhan, J Gardner, C Bailey, A Cohen</div><div class="gs_gray">Seminars in thrombosis and hemostasis 28 (06), 569-576<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13406036674436141937" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:3htObqc8RwsC" class="gsc_a_at">Incident atrial fibrillation, dementia and the role of anticoagulation: a population-based cohort study</a><div class="gs_gray">TS Field, B Weijs, A Curcio, M Giustozzi, S Sudikas, A Katholing, ...</div><div class="gs_gray">Thrombosis and haemostasis 119 (06), 981-991<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10349070853936562151" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Discoveries in thrombosis care for medical patients</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Seminars in thrombosis and hemostasis 28 (s3), 013-018<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2625232996445456" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Choosing wisely: the impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials</a><div class="gs_gray">J Beyer-Westendorf, AWA Lensing, R Arya, H Bounameaux, AT Cohen, ...</div><div class="gs_gray">Thrombosis research 149, 29-37<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16519038845031668172" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:bKqednn6t2AC" class="gsc_a_at">Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists</a><div class="gs_gray">MPA Brekelmans, SM Bleker, R Bauersachs, Z Boda, HR Büller, Y Choi, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (07), 155-161<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10250416938827958756" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE&nbsp;…</a><div class="gs_gray">P Prandoni, MH Prins, AT Cohen, K Müller, ÁF Pap, MC Tewes, ...</div><div class="gs_gray">Academic Emergency Medicine 22 (2), 142-149<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17802810019077102095" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">An adaptive‐design dose‐ranging study of PD 0348292, an oral factor X a inhibitor, for thromboprophylaxis after total knee replacement surgery</a><div class="gs_gray">AT Cohen, RA Boyd, JW Mandema, L Dicarlo, R Pak, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11 (8), 1503-1510<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2848703853669391607" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Rivaroxaban vs. enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: Magellan subgroup analyses: O-MO-034</a><div class="gs_gray">A Cohen, T Spiro, H Buller, L Haskell, D Hu, R Hull, A Mebazaa, G Merli, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15731564763155346365" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Amputation for premature peripheral atherosclerosis: do young patients do better?</a><div class="gs_gray">JA Skinner, AT Cohen</div><div class="gs_gray">The Lancet 348 (9039), 1396<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14630934113549610918" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dshw04ExmUIC" class="gsc_a_at">Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries</a><div class="gs_gray">LH Chuang, P Gumbs, B van Hout, G Agnelli, S Kroep, M Monreal, ...</div><div class="gs_gray">Quality of Life Research 28 (8), 2111-2124<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3982243525093974226" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy</a><div class="gs_gray">G Chi, CM Gibson, A Kalayci, AT Cohen, AF Hernandez, RD Hull, F Kahe, ...</div><div class="gs_gray">Intensive care medicine 45 (4), 477-487<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7888213659812562990" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:9pM33mqn1YgC" class="gsc_a_at">COSIMO–patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study</a><div class="gs_gray">AT Cohen, A Maraveyas, J Beyer-Westendorf, AYY Lee, LG Mantovani, ...</div><div class="gs_gray">Thrombosis journal 16 (1), 1-9<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9082842574275880010" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:blknAaTinKkC" class="gsc_a_at">Use of direct oral anticoagulants in patients with cancer: practical considerations for the management of patients with nausea or vomiting</a><div class="gs_gray">H Riess, C Ay, R Bauersachs, C Becattini, J Beyer‐Westendorf, ...</div><div class="gs_gray">The oncologist 23 (7), 822<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2259470376982203909" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:URolC5Kub84C" class="gsc_a_at">Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: an analysis of the randomized, double-blind&nbsp;…</a><div class="gs_gray">T Vanassche, P Verhamme, PS Wells, A Segers, W Ageno, ...</div><div class="gs_gray">Thrombosis research 162, 7-14<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7423291666721206346" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-f6ydRqryjwC" class="gsc_a_at">A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight&nbsp;…</a><div class="gs_gray">JD Smith, J Baillie, T Baglin, GO Griffiths, A Casbard, D Cohen, ...</div><div class="gs_gray">Trials 15 (1), 1-12<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1730739982143504332" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">Direct oral anticoagulant concentrations in obese and high body weight patients: a cohort study</a><div class="gs_gray">AC Martin, W Thomas, Z Mahir, MP Crowley, T Dowling, K Breen, ...</div><div class="gs_gray">Thrombosis and haemostasis 121 (02), 224-233<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1520487399220234715" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial</a><div class="gs_gray">MK Yee, T Nafee, Y Daaboul, S Korjian, F AlKhalfan, M Kerneis, C Wiest, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 45 (1), 1-8<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17801670036617178379" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Thromboprophylaxis in non-surgical cancer patients</a><div class="gs_gray">AT Cohen, MMP Gurwith, M Dobromirski</div><div class="gs_gray">Thrombosis research 129, S137-S145<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3314652868431219726" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Prevention of postoperative venous thromboembolism</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Bmj 339<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1393456607970116585" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:TQgYirikUcIC" class="gsc_a_at">Machine learning to predict venous thrombosis in acutely ill medical patients</a><div class="gs_gray">T Nafee, CM Gibson, R Travis, MK Yee, M Kerneis, G Chi, F AlKhalfan, ...</div><div class="gs_gray">Research and practice in thrombosis and haemostasis 4 (2), 230-237<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1838591102878069578" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:r0BpntZqJG4C" class="gsc_a_at">When academic research organizations and clinical research organizations disagree: processes to minimize discrepancies prior to unblinding of randomized trials</a><div class="gs_gray">CM Gibson, SZ Goldhaber, AT Cohen, T Nafee, AF Hernandez, R Hull, ...</div><div class="gs_gray">American heart journal 189, 1-8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1968725216289066790" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5awf1xo2G04C" class="gsc_a_at">Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism</a><div class="gs_gray">X Liu, J Thompson, H Phatak, J Mardekian, A Porcari, M Johnson, ...</div><div class="gs_gray">Thrombosis and haemostasis 115 (01), 161-168<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5699053422341277088" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence?</a><div class="gs_gray">AT Cohen, L Maillardet, Y Yavin</div><div class="gs_gray">Thrombosis and haemostasis 101 (03), 422-427<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5736400189353984530" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">The National VTe exemplar centres network response to implementation of updated NICE guidance: venous thromboembolism in over 16S: reducing the risk of hospital-acquired deep&nbsp;…</a><div class="gs_gray">E Gee</div><div class="gs_gray">British journal of haematology 186 (5), 792-793<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12984728907921663547" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Rivaroxaban and the EINSTEIN clinical trial programme</a><div class="gs_gray">AT Cohen, R Bauersachs</div><div class="gs_gray">Blood Coagulation &amp; Fibrinolysis 30 (3), 85<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=271195584154503320" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study</a><div class="gs_gray">AT Cohen, C Ay, P Hainaut, H Décousus, U Hoffmann, S Gaine, ...</div><div class="gs_gray">Thrombosis journal 16 (1), 1-13<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7116807240367975561" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Pulmonary embolism in Europe-Burden of illness in relationship to healthcare resource utilization and return to work</a><div class="gs_gray">SN Willich, LH Chuang, B van Hout, P Gumbs, D Jimenez, S Kroep, ...</div><div class="gs_gray">Thrombosis research 170, 181-191<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13124351677263812553" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences</a><div class="gs_gray">T Lanitis, R Leipold, M Hamilton, D Rublee, P Quon, C Browne, AT Cohen</div><div class="gs_gray">BMC health services research 17 (1), 1-14<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10867248423898056211" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Cost-effectiveness of apixaban versus other oral anticoagulants for the initial treatment of venous thromboembolism and prevention of recurrence</a><div class="gs_gray">T Lanitis, R Leipold, M Hamilton, D Rublee, P Quon, C Browne, AT Cohen</div><div class="gs_gray">Clinical therapeutics 38 (3), 478-493. e16<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17257778475655341010" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:w0F2JDEymm0C" class="gsc_a_at">Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data</a><div class="gs_gray">J Beyer-Westendorf, AT Cohen, M Monreal</div><div class="gs_gray">European Heart Journal Supplements 17 (suppl_D), D32-D41<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14939278933561066809" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach</a><div class="gs_gray">SA Black, AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 114 (10), 660-669<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3784458906196102443" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_xSYboBqXhAC" class="gsc_a_at">VTE primary prevention, including hospitalised medical and orthopaedic surgical patients</a><div class="gs_gray">S Granziera, AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 113 (06), 1216-1223<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3478173541484176314" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Epidemiology of fatal pulmonary embolism in non-surgical patients.</a><div class="gs_gray">R Alikhan, F Peters, R Wilmott, J Gardner, AT Cohen</div><div class="gs_gray">Blood 100 (11), 276A-276A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3492962658631306686" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:otzGkya1bYkC" class="gsc_a_at">Liver transplantation for metabolic disorders</a><div class="gs_gray">A Cohen, J O'Grady, A Mowat, R Williams</div><div class="gs_gray">Baillière's clinical gastroenterology 3 (4), 767-786<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12229707245540048034" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Anticoagulant selection for patients with VTE—Evidence from a systematic literature review of network meta-analyses</a><div class="gs_gray">AT Cohen, SE Berger, D Milenković, NR Hill, S Lister</div><div class="gs_gray">Pharmacological research 143, 166-177<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5543437815436252378" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Deep-vein thrombosis in Europe—burden of illness in relationship to healthcare resource utilization and return to work</a><div class="gs_gray">LH Chuang, B Van Hout, AT Cohen, PD Gumbs, S Kroep, R Bauersachs, ...</div><div class="gs_gray">Thrombosis research 170, 165-174<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17377353409570145377" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yD5IFk8b50cC" class="gsc_a_at">The role of heparin lead-in in the real-world management of acute venous thromboembolism: the PREFER in VTE registry</a><div class="gs_gray">R Bauersachs, G Agnelli, AK Gitt, M Monreal, P Mismetti, SN Willich, ...</div><div class="gs_gray">Thrombosis research 157, 181-188<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3345616071401641827" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Variation in the association between antineoplastic therapies and venous thromboembolism in patients with active cancer</a><div class="gs_gray">M Giustozzi, A Curcio, B Weijs, TS Field, S Sudikas, A Katholing, ...</div><div class="gs_gray">Thrombosis and haemostasis 120 (05), 847-856<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7481567178909116226" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Clinical impact and course of anticoagulant-related major bleeding in cancer patients</a><div class="gs_gray">N Kraaijpoel, N van Es, SM Bleker, MPA Brekelmans, ES Eerenberg, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (01), 174-181<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11416430132904630357" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy</a><div class="gs_gray">G Chi, JL Januzzi, S Korjian, Y Daaboul, SZ Goldhaber, AF Hernandez, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 44 (4), 457-465<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12098859478220446779" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Impact of thromboprophylaxis across the US acute care setting</a><div class="gs_gray">W Huang, FA Anderson, SK Rushton-Smith, AT Cohen</div><div class="gs_gray">PloS one 10 (3), e0121429<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13478191993325297176" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a&nbsp;…</a><div class="gs_gray">AT Cohen, R Harrington, SZ Goldhaber, R Hull, CM Gibson, ...</div><div class="gs_gray">American heart journal 169 (1), 186-187<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14896361368623174773" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Venous thromboembolism prophylaxis for the medical patient: where do we stand?</a><div class="gs_gray">Y Yavin, AT Cohen</div><div class="gs_gray">Seminars in respiratory and critical care medicine 29 (01), 075-082<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7293762499632974743" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty</a><div class="gs_gray">OE Dahl, M Ögren, G Agnelli, BI Eriksson, AT Cohen, P Mouret, ...</div><div class="gs_gray">Pathophysiology of haemostasis and thrombosis 35 (6), 428-434<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4387925620759349258" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Review of venous thromboembolism associated with air travel</a><div class="gs_gray">A Tasker, O Akinola, AT Cohen</div><div class="gs_gray">Travel medicine and infectious disease 2 (2), 75-79<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=588666190948935371" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Applying risk assessment models in orthopaedic surgery: effective risk stratification.</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Blood coagulation &amp; fibrinolysis: an international journal in haemostasis&nbsp;…<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12384629229104612936" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Loss of heparin-releasable tissue factor pathway inhibitor in patients undergoing PTCA</a><div class="gs_gray">S Anderson, AT Cohen, E Melissari, MS Scully, VV Kakkar</div><div class="gs_gray">Thrombosis and haemostasis 73 (02), 328-329<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7124363375132333657" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Extended-duration thromboprophylaxis among acute medically ill patients: an unmet need</a><div class="gs_gray">S Korjian, Y Daaboul, R Halaby, SZ Goldhaber, AT Cohen, K Singh, ...</div><div class="gs_gray">Journal of cardiovascular pharmacology and therapeutics 21 (3), 227-232<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4956864322839516903" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study.</a><div class="gs_gray">D Bergqvist, G Agnelli, AT Cohen, PE Nilsson, A Le Moigne-Amrani, ...</div><div class="gs_gray">Blood 100 (11), 502A-502A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1123996062292712757" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Characteristics and outcomes in patients with venous thromboembolism taking concomitant anti-platelet agents and anticoagulants in the AMPLIFY trial</a><div class="gs_gray">AT Cohen, G Agnelli, HR Buller, A Gallus, GE Raskob, P Sanders, ...</div><div class="gs_gray">Thrombosis and haemostasis 119 (03), 461-466<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1609047355489232483" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">State of play and future direction with NOACs: An expert consensus</a><div class="gs_gray">AT Cohen, GY Lip, R De Caterina, H Heidbuchel, JL Zamorano, G Agnelli, ...</div><div class="gs_gray">Vascular pharmacology 106, 9-21<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18433660844666181101" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:m4fbC6XIj1kC" class="gsc_a_at">Investigators A</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ...</div><div class="gs_gray">Oral apixaban for the treatment of acute venous thromboembolism. N Engl J&nbsp;…<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17603603774487997844" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:lg2tdxc6qMwC" class="gsc_a_at">SARS-CoV-2 vaccine and thrombosis: an expert consensus on vaccine-induced immune thrombotic thrombocytopenia</a><div class="gs_gray">I Elalamy, G Gerotziafas, S Alamowitch, JP Laroche, P Van Dreden, ...</div><div class="gs_gray">Thrombosis and Haemostasis 121 (08), 982-991<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16853563140198842323" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:v1_lew4L6wgC" class="gsc_a_at">The global edoxaban treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design</a><div class="gs_gray">R De Caterina, G Agnelli, P Laeis, M Unverdorben, H Rauer, CC Wang, ...</div><div class="gs_gray">Clinical cardiology 42 (12), 1147-1154<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12501649349261394313" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States</a><div class="gs_gray">H Guy, V Laskier, M Fisher, WR Neuman, I Bucior, S Deitelzweig, ...</div><div class="gs_gray">PharmacoEconomics 37 (5), 701-714<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5922845721792221450" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:mB3voiENLucC" class="gsc_a_at">Association of D-dimer levels with clinical event rates and the efficacy of betrixaban versus enoxaparin in the APEX trial</a><div class="gs_gray">CM Gibson, LK Jennings, G Chi, MK Yee, R Halaby, T Nafee, F AlKhalfan, ...</div><div class="gs_gray">TH Open 2 (01), e16-e24<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1792329151735602517" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy</a><div class="gs_gray">DF Arbetter, P Jain, MK Yee, N Michalak, AF Hernandez, RD Hull, ...</div><div class="gs_gray">Pharmaceutical statistics 16 (6), 445-450<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16403218844861277461" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Patency rates after stenting across the inguinal ligament for treatment of post-thrombotic syndrome using nitinol venous stents</a><div class="gs_gray">P Saha, A Gwozdz, D Hagley, T El-Sayed, B Hunt, V McDonald, A Cohen, ...</div><div class="gs_gray">Journal of Vascular Surgery: Venous and Lymphatic Disorders 5 (1), 148<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17068684128630152437" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association</a><div class="gs_gray">D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...</div><div class="gs_gray">Heart disease and stroke statistics-2016 update. Circulation 133, e38-e360<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9638738354911546971" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Oral rivaroxaban for the treatment of symptomatic pulmonary embolism</a><div class="gs_gray">HR Buller, MH Prins, AWA Lensing, H Decousus, BF Jacobson, E Minar, ...</div><div class="gs_gray">New England Journal of Medicine 366 (14), 1287-1297<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8028524412165010632" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Fondaparinux reduces symptomatic pulmonary embolism and death in patients hospitalized with congestive heart failure: a sub-analysis of the randomized ARTEMIS trial [abstract P477]</a><div class="gs_gray">J Eikelboom, AT Cohen, AGG Turpie</div><div class="gs_gray">Eur Heart J 28 (Suppl 1), 50<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6722469373546525648" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">The significance of distal vein thrombosis and bilateral disease</a><div class="gs_gray">AT Cohen, M Wolozinsky</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 3 (7), 1360-1361<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12043186176445719727" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Use of thromboprophylaxis in nonsurgical patients: Survey of a London teaching hospital.</a><div class="gs_gray">R Alikhan, R Wilmott, S Agrawal, N Desouza, A Gera, H Zaw, J Gardner, ...</div><div class="gs_gray">Blood 98 (11), 271A-271A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12500203966487364029" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">A comparison of endoxaparin with placebo for prevention of venous throm boembolism in acutely ili medical patients</a><div class="gs_gray">M Şamama, A Cohen, JY Darmon</div><div class="gs_gray">N Engl J Med 341, 739-800<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1309723394027947495,16435048252005122429,5713139443907802114,15771614259686883235" class="gsc_a_ac gs_ibl">7</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="YtROf4UAAAAJ:YOwf2qJgpHMC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:8AbLer7MMksC" class="gsc_a_at">Low-molecular-weight heparin for venous thrombosis in a neonate</a><div class="gs_gray">SM Dzumhur, DE Goss, AT Cohen</div><div class="gs_gray">The Lancet 346 (8988), 1487<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4602201653166246391" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Increased risk of death in acutely ill medical patients with asymptomatic proximal deep vein thrombosis or symptomatic venous thromboembolism: insights from the MAGELLAN study</a><div class="gs_gray">GE Raskob, AC Spyropoulos, AT Cohen, JI Weitz, W Ageno, Y De Sanctis, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9743073888145177485" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">The impact of co-morbidity on the disease burden of VTE</a><div class="gs_gray">S Kroep, LH Chuang, A Cohen, P Gumbs, B van Hout, M Monreal, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 46 (4), 507-515<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17224126856062455650" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YohjEiUPhakC" class="gsc_a_at">Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin</a><div class="gs_gray">P Prandoni, AWA Lensing, MH Prins, M Gebel, AF Pap, M Homering, ...</div><div class="gs_gray">Thrombosis research 168, 121-129<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8957398751059242145" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Betrixaban in Acutely Ill Medical Patients.</a><div class="gs_gray">R Patil, K Ghosh, S Shetty</div><div class="gs_gray">The New England journal of medicine 375 (24), e50-e50<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14251249598477096707" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:__bU50VfleQC" class="gsc_a_at">Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight: AS099</a><div class="gs_gray">M Prins, M Nisio, M Vedovati, A Riera-Mestre, K Mueller, A Cohen, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13, 35-36<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18139373428249627138" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">The current use of direct oral anticoagulants (DOACs) for the treatment of VTE in Europe-PREFER in VTE</a><div class="gs_gray">G Agnelli, R Bauersachs, AK Gitt, P Laeis, P Mismetti, M Monreal, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 1002-1002<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5384059359395953477" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:jSAVyFp_754C" class="gsc_a_at">Vitamin K antagonist treatment patterns and persistence after venous thromboembolism in noncancer patients: VTE Epidemiology Group (VEG) Study: AS 17.2</a><div class="gs_gray">A Cohen, C Martinez, C Wallenhorst, L Bamber</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16232429651105931929" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Are isolated distal deep-vein thromboses clinically significant?</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Clinical Practice 5 (2), 151<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15469233106656284387" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:48xauSegjOkC" class="gsc_a_at">Pharmacological prevention of venous thromboembolism in medical patients at risk</a><div class="gs_gray">M Wolozinsky, YY Yavin, AT Cohen</div><div class="gs_gray">American journal of cardiovascular drugs 5 (6), 409-415<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12276059845538998112" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Patients at risk of venous thromboembolism—Clinical results with reviparin</a><div class="gs_gray">VV Kakkar, AT Cohen, MS Mohamed</div><div class="gs_gray">Thrombosis research 81 (2), S39-S45<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2600401608207287013" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective</a><div class="gs_gray">AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ...</div><div class="gs_gray">Thrombosis and Haemostasis 120 (06), 924-936<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14353256640854790447" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">MACE and VTE across multiple upadacitinib studies in rheumatoid arthritis: integrated analysis from the SELECT phase 3 clinical program</a><div class="gs_gray">E Choy, LB McInnes, J Cush, J Aelion, Y Zhang, N Khan, J Liu, HS Camp, ...</div><div class="gs_gray">JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 26, 11-11<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4542130841597201071" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:GnPB-g6toBAC" class="gsc_a_at">30 day mortality following andexanet alfa in annexa-4 compared with prothrombin complex concentrate (Pcc) therapy in the orange study for life threatening non-vitamin k oral&nbsp;…</a><div class="gs_gray">AT Cohen, M Lewis, A Connor, S Connolly, P Yue, J Curnutte, ...</div><div class="gs_gray">Journal of the American College of Cardiology 75 (11_Supplement_1), 2242-2242<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2351126618843070469" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:C33y2ycGS3YC" class="gsc_a_at">Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial</a><div class="gs_gray">W Ageno, RD Lopes, MK Yee, A Hernandez, R Hull, SZ Goldhaber, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 49 (2), 214-219<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4802161114877631942" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Prevention of venous thromboembolism in ambulatory patients with cancer</a><div class="gs_gray">AA Khorana, AT Cohen, M Carrier, G Meyer, I Pabinger, P Kavan, ...</div><div class="gs_gray">Esmo Open 5 (6), e000948<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9880076658807381697" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0N-VGjzr574C" class="gsc_a_at">Estimation of acutely ill medical patients at venous thromboembolism risk eligible for extended thromboprophylaxis using APEX criteria in US hospitals</a><div class="gs_gray">AC Martin, W Huang, SZ Goldhaber, RD Hull, AF Hernandez, CM Gibson, ...</div><div class="gs_gray">Clinical and Applied Thrombosis/Hemostasis 25, 1076029619880008<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8633100297342382293" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis</a><div class="gs_gray">LH Chuang, AT Cohen, G Agnelli, PD Gumbs, R Bauersachs, S Kroep, ...</div><div class="gs_gray">Quality of Life Research 28 (5), 1155-1177<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3234226170110124794" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Determinants of the quality of warfarin control after venous thromboembolism and validation of the SAMe-TT2-R2 score: an analysis of Hokusai-VTE</a><div class="gs_gray">S Barco, S Granziera, M Coppens, J Douxfils, M Nijkeuter, N Riva, ...</div><div class="gs_gray">Thrombosis and haemostasis 119 (04), 675-684<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5328927527153786409" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Br1UauaknNIC" class="gsc_a_at">Reduction of cardiovascular mortality and ischemic events in acute medically ill patients: an APEX Substudy</a><div class="gs_gray">T Nafee, CM Gibson, MK Yee, M Kerneis, Y Daaboul, S Korjian, G Chi, ...</div><div class="gs_gray">Circulation 139 (9), 1234-1236<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13612196264373760343" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Extended thromboprophylaxis with betrixaban: a new standard for acute medically ill patients</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">European heart journal supplements: journal of the European Society of&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5971254933306968052" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Full-dose betrixaban reduces venous thromboembolism-related mortality: an APEX trial substudy</a><div class="gs_gray">CM Gibson, T Nafee, SZ Goldhaber, AF Hernandez, RD Hull, A Gold, ...</div><div class="gs_gray">Circulation 136 (suppl_1), A20393-A20393<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8738385403578336390" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Two doses of apixaban for the extended treatment of venous thromboembolism</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, MR Johnson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), LBA-1-LBA-1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13461032557778490292" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Risque thromboembolique veineux et pratique de prévention hospitalière: Résultats obtenus en France de l’étude internationale ENDORSE</a><div class="gs_gray">JF Bergmann, C Lloret-Linares, A Rami, AT Cohen, RP Garay, AK Kakkar, ...</div><div class="gs_gray">La Presse Médicale 40 (12), e528-e537<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5122055804162824350" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:D_sINldO8mEC" class="gsc_a_at">Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing cancer surgery: long-term survival analysis</a><div class="gs_gray">D Bergqvist, G Agnelli, AT Cohen, PE Nilsson, AL Moigne-Amrani, ...</div><div class="gs_gray">Phlebology 21 (4), 195-198<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4803995625494538578" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Estimated Annual Number of US Acute-Care Hospital Inpatients Meeting ACCP Criteria for Venous Thromboembolism (VTE) Prophylaxis.</a><div class="gs_gray">FA Anderson Jr, M Zayaruzny, JA Heit, AT Cohen</div><div class="gs_gray">Blood 106 (11), 903<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13937941408131551409" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin</a><div class="gs_gray">BI Eriksson, G Agnelli, A Cohen, O Dahl, P Mouret, N Rosencher, ...</div><div class="gs_gray">Thrombosis and haemostasis 92 (08), 428-430<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16135073266734101340" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Efficacy and safety of combining dalteparin with aspirin in preventing venous thromboembolism in medical patients.</a><div class="gs_gray">A Leizorovicz, AT Cohen, AG Turpie, CG Olsson, PT Vaitkus, JI Weitz, ...</div><div class="gs_gray">Blood 102 (11), 321A-321A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17998982038169245283" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Benefit of enoxaparin in medical patients. A subgroup analysis.</a><div class="gs_gray">R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...</div><div class="gs_gray">Blood 98 (11), 266A-266A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8798939559657123631" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:R-LXmdHK_14C" class="gsc_a_at">Association between asymptomatic proximal deep vein thrombosis and mortality in acutely ill medical patients</a><div class="gs_gray">GE Raskob, AC Spyropoulos, AT Cohen, JI Weitz, W Ageno, Y De Sanctis, ...</div><div class="gs_gray">Journal of the American Heart Association 10 (5), e019459<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11724919770593338310" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Effectiveness and safety of apixaban, low-molecular-weight heparin, and warfarin among venous thromboembolism patients with active cancer: a US claims data analysis</a><div class="gs_gray">A Cohen, A Keshishian, T Lee, G Wygant, L Rosenblatt, P Hlavacek, ...</div><div class="gs_gray">Thrombosis and haemostasis 121 (03), 383-395<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5780341663700150892" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:t-hv7AR41mYC" class="gsc_a_at">ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries</a><div class="gs_gray">AT Cohen, U Hoffmann, P Hainaut, S Gaine, C Ay, M Coppens, ...</div><div class="gs_gray">European journal of internal medicine 82, 48-55<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7972373308873228003" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dAp6zn-oMfAC" class="gsc_a_at">THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM</a><div class="gs_gray">E Choy, I McInnes, J Cush, J Aelion, W Rigby, Y Song, S Meerwein, J Liu, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 79 (Suppl 1), 317-318<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4750181320174579745" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WZBGuue-350C" class="gsc_a_at">Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses</a><div class="gs_gray">D Weycker, GDV Wygant, JD Guo, T Lee, X Luo, L Rosenblatt, ...</div><div class="gs_gray">Blood advances 4 (2), 432-439<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8142857936981341901" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">A systematic review of network meta-analyses and real-world evidence comparing apixaban and rivaroxaban in nonvalvular atrial fibrillation</a><div class="gs_gray">NR Hill, B Sandler, E Bergrath, D Milenković, AO Ashaye, U Farooqui, ...</div><div class="gs_gray">Clinical and Applied Thrombosis/Hemostasis 26, 1076029619898764<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4208226329043839753" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Explaining the slowdown in medical spending growth among the elderly, 1999-2012.</a><div class="gs_gray">SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ...</div><div class="gs_gray">RTI International<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14572002398195415778" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Deep vein thrombosis in Europe—health-related quality of life and mortality</a><div class="gs_gray">M Monreal, G Agnelli, LH Chuang, AT Cohen, PD Gumbs, R Bauersachs, ...</div><div class="gs_gray">Clinical and Applied Thrombosis/Hemostasis 25, 1076029619883946<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11938710252724622910" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Patient preferences regarding anticoagulation therapy in patients with cancer having a VTE event-a Discrete Choice Experiment in the COSIMO study</a><div class="gs_gray">N Picker, AT Cohen, A Maraveyas, J Beyer-Westendorf, AYY Lee, ...</div><div class="gs_gray">Blood 134, 2159<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11773335507286259689" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:q-HalDI95KYC" class="gsc_a_at">Outpatient management in patients with venous thromboembolism with edoxaban: a post hoc analysis of the Hokusai-VTE Study</a><div class="gs_gray">A Medina, G Raskob, W Ageno, AT Cohen, MPA Brekelmans, CZ Chen, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (12), 2406-2414<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13913726861985711116" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Betrixaban reduces the burden of multiple symptomatic venous thromboembolic events in the APEX trial</a><div class="gs_gray">P Jain, DA Szlosek, S Korjian, Y Daaboul, RD Lopes, SZ Goldhaber, ...</div><div class="gs_gray">Circulation 134 (suppl_1), A19325-A19325<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11686482606298124033" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Cost-effectiveness of apixaban compared to low molecular weight heparin/edoxaban for treatment and prevention of recurrent venous thromboembolism</a><div class="gs_gray">T Lanitis, M Hamilton, P Quon, C Browne, C Masseria, AT Cohen</div><div class="gs_gray">Value in Health 18 (7), A375-A376<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8874478775162469582" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants</a><div class="gs_gray">A Cohen, S Jeyaindran, JY Kim, K Park, S Sompradeekul, KL Tambunan, ...</div><div class="gs_gray">Thrombosis research 136 (2), 196-207<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3276444123395760334" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Cost-effectiveness of apixaban compared to other anticoagulants for lifetime treatment and prevention of recurrent venous thromboembolism</a><div class="gs_gray">T Lanitis, M Hamilton, DA Rublee, R Leipold, P Quon, C Browne, ...</div><div class="gs_gray">Value in Health 17 (7), A488<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17082931297384584145" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:lgwcVrK6X84C" class="gsc_a_at">The MAGELLAN study: an analysis of outcomes utilizing D-dimer</a><div class="gs_gray">AT Cohen, TE Spiro, P Burton, HR Büller, L Haskell, DY Hu, RD Hull, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 542-542<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12290122331760772835" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study (vol 371, pg 387, 2008)</a><div class="gs_gray">AT Cohen, VF Tapson, JF Bergmann</div><div class="gs_gray">Lancet 371 (9628), 1914-1914<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12400380687810085917" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Risque de maladie thromboembolique veineuse et pratique de préventions hospitalières en médecine interne: résultas obtenus en France de l’étude internationale ENDORSE</a><div class="gs_gray">JF Bergmann, AT Cohen, VF Tapson, AK Kakkar, SZ Goldhaber, M Behar, ...</div><div class="gs_gray">La Revue de médecine interne, S397<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8405730660520867400" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Aspirin in the prevention and treatment of venous thromboembolism: a rebuttal</a><div class="gs_gray">L Maillardet, AT Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 5 (1), 212-213<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13653540197136682901" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Venous thromboembolic disease in cancer patients in Europe-an opportunity for improved prevention: the VITAE Thrombosis Study</a><div class="gs_gray">AT Cohen, AK Kakkar</div><div class="gs_gray">EJC SUPPLEMENTS 3 (2), 156-156<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14931742800497970773" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Venous thromboembolism risk assessment in medical patients.</a><div class="gs_gray">AT Cohen, R Alikhan, J Arcelus, S Haas, A Spyropoulos, V Tapson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14844765693398905189" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Prolonged thromboprophylaxis in patients undergoing abdominal cancer surgery with enoxaparin: The enoxacan II study.</a><div class="gs_gray">A Eldor, D Bergqvist, G Agnelli, AT Cohen, PE Nilsson, ...</div><div class="gs_gray">Blood 98 (11), 706A-706A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7043351486833411363" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">DERMATAN SULFATE FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT) IN ELECTIVE HIP-SURGERY-A DOSE-FINDING TRIAL</a><div class="gs_gray">AT Cohen, MJ Phillips, RA Edmondson, E Melissari, I Vaidyanathan, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 621-621<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16138426882118740881" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Prevention of venous thromboembolism after major abdominal surgery</a><div class="gs_gray">MA McNally, WG Kernohan, JG Brown, MD Laverick, RAB Mollan, ...</div><div class="gs_gray">The Lancet 341 (8848), 823-825<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3147878476946579526" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:n3vGvpFsckwC" class="gsc_a_at">Effectiveness and safety of apixaban vs. warfarin in venous thromboembolism patients with obesity and morbid obesity</a><div class="gs_gray">A Cohen, J Sah, T Lee, L Rosenblatt, P Hlavacek, B Emir, A Keshishian, ...</div><div class="gs_gray">Journal of clinical medicine 10 (2), 200<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3044463607293181430" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more</a><div class="gs_gray">W Ageno, RD Lopes, MK Yee, A Hernandez, RD Hull, SZ Goldhaber, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 17 (12), 2089-2098<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10464224178617889550" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Rivaroxaban for extended thromboprophylaxis after hospitalization for medical illness: pooled analysis of mortality and major thromboembolic events in 16,496 patients from the&nbsp;…</a><div class="gs_gray">GE Raskob, A Spyropoulos, AT Cohen, T Spiro, W Lu, B Levitan, EY Suh, ...</div><div class="gs_gray">Circulation 140 (Suppl_1), A12863-A12863<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8620843604850401047" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Safety and effectiveness of apixaban, LMWH, and warfarin among venous thromboembolism patients with active cancer: a retrospective analysis using four US claims databases</a><div class="gs_gray">AT Cohen, A Keshishian, T Lee, G Wygant, L Rosenblatt, P Hlavacek, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14859402896226832435" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Employment Cost Index, Historical Listing–Volume V: Continuous Occupational and Industry Series: September 1975-December 2017. Table 4: employment cost index for total…</a><div class="gs_gray">EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ...</div><div class="gs_gray">RTI International<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11540067286585277315" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_B80troHkn4C" class="gsc_a_at">Magnitude of venous thromboembolism risk in US hospitals: impact of evolving national guidelines for prevention of venous thromboembolism</a><div class="gs_gray">W Huang, AT Cohen, AC Martin, FA Anderson</div><div class="gs_gray">The American journal of medicine 132 (5), 588-595<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5459899498225144385" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK</a><div class="gs_gray">E Clay, A Jamotte, P Verhamme, AT Cohen, BA Van Hout, P Gumbs</div><div class="gs_gray">Journal of market access &amp; health policy 6 (1), 1495974<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8134562529588101689" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Direct oral anticoagulants for pulmonary embolism: importance of anatomical extent</a><div class="gs_gray">MPA Brekelmans, HR Büller, MF Mercuri, W Ageno, CZ Chen, AT Cohen, ...</div><div class="gs_gray">TH Open 2 (01), e1-e7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7931279572542484554" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Mojj43d5GZwC" class="gsc_a_at">The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell disease</a><div class="gs_gray">M Wijnberge, K Parmar, R Kesse-Adu, J Howard, AT Cohen, BJ Hunt</div><div class="gs_gray">Thrombosis research 158, 113-120<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5325092614864927825" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Impact of evolving ACCP guidelines on estimates of venous thromboembolism risk in US hospitals</a><div class="gs_gray">W Huang, A Cohen, M Zayaruzny, A Wyman, F Anderson</div><div class="gs_gray">Age 18, 39<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14032947804280668556" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">Secondary thromboprophylaxis with rivaroxaban in major inherited thrombophilias: PO578-WED</a><div class="gs_gray">K Schreiber, S Sciascia, A Cohen, B Hunt</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16227801352489470756" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Time in therapeutic range (TTR) and relative efficacy and safety of treatment with apixaban or enoxaparin/warfarin for acute symptomatic venous thromboembolism: an analysis of&nbsp;…</a><div class="gs_gray">A Cohen, AS Gallus, G Agnelli, HR Buller, R Pak, AR Porcari, GE Raskob, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1543-1543<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11616266561456054186" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-yGd096yOn8C" class="gsc_a_at">Excellence, quality and limitations of the NICE venous thromboembolism score tool: how can it be improved?</a><div class="gs_gray">AT Cohen, S Granziera</div><div class="gs_gray">British journal of haematology 167 (5), 702-704<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18205098817682683808" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Treatment satisfaction in patients with venous thromboembolism as measured with pact-Q2: prefer in vte registry</a><div class="gs_gray">SN Willich, R Bauersachs, AK Gitt, P Mismetti, M Monreal, WP Wolf, ...</div><div class="gs_gray">Value in Health 17 (7), A496-A497<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12768293856996440302" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Health state in patients with venous thromboembolism on conventional and non-Vka oral anticoagulants as assessed with the Eq-5d-5l questionnaire: prefer in Vte registry</a><div class="gs_gray">AT Cohen, R Bauersachs, AK Gitt, P Mismetti, M Monreal, SN Willich, ...</div><div class="gs_gray">Value in Health 17 (7), A493-A494<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12458651886837230917" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Apixaban reduces hospitalizations in patients with VTE: an analysis of the AMPLIFY trial</a><div class="gs_gray">X Liu, M Johnson, J Mardekian, H Phatak, J Thompson, A Cohen</div><div class="gs_gray">Journal of the American College of Cardiology 63 (12S), A2045-A2045<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3956231206854303071" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Aspirin versus low-molecular-weight heparin after total hip arthroplasty</a><div class="gs_gray">S Granziera, AT Cohen</div><div class="gs_gray">Annals of internal medicine 159 (7), 502<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4529910644943343930" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:TlpoogIpr_IC" class="gsc_a_at">There's madness in their methods–a response to: Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the&nbsp;…</a><div class="gs_gray">A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11 (4), 782-785<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16089932184742033469" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Apixaban pour le traitement de la thromboembolie veineuse</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray">Minerva 12 (9), 114-115<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5614538451988260717" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Venous thromboembolism: The magnitude of the problem in Europe and the world</a><div class="gs_gray">AT Cohen, M Dobromirski, SL Lin, JO Wills</div><div class="gs_gray">Advances in Venous Arterial Thrombosis 1 (2), 39<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8686901778180619410" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HIFyuExEbWQC" class="gsc_a_at">1123-182 Obesity does not attenuate the effectiveness of low-dose dalteparin in preventing venous thromboembolism in medically III patients</a><div class="gs_gray">N Kucher, A Leizorovicz, AT Cohen, AG Turpie, CG Olsson, PT Vaitkus, ...</div><div class="gs_gray">Journal of the American College of Cardiology 43 (5S2), A501-A501<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10032585201969807023" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1taIhTC69MYC" class="gsc_a_at">Mortality is increased in patients with proximal, but not distal, deep vein thrombosis in medically ill patients entered in the PREVENT trial.</a><div class="gs_gray">PT Vaitkus, A Leizorovicz, SZ Goldhaber, CG Olsson, AT Cohen, JI Weitz, ...</div><div class="gs_gray">Blood 102 (11), 165A-166A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12932348774432581194" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Venous ultrasound: An alternative to venography for evaluation of Dalteparin prophylaxis in 3,706 medically ill hospitalized patients.</a><div class="gs_gray">F Becker, A Leizorovicz, CG Olsson, AT Cohen, PT Vaitkus, AG Turpie, ...</div><div class="gs_gray">Blood 102 (11), 324A-325A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1919018230532271384" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Ehil0879vHcC" class="gsc_a_at">SHAPE: A Pan-European general public heart failure awareness and survey</a><div class="gs_gray">W Remme, C Cline, A Cohen, R Hobbs, K Keukelaar, JL Sendon, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10754741399403264967" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Generalisations on benefits of aspirin are dangerous</a><div class="gs_gray">D Quinlan, A Cohen</div><div class="gs_gray">Bmj 321 (7260), 569<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16207138085300321957" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:silx2ntsSuwC" class="gsc_a_at">CORRESPONDENCE-PEP trial</a><div class="gs_gray">A Cohen, D Quinlan, C Cimminiello, I Mahd, SM Tauzeeh, Y Smulders, ...</div><div class="gs_gray">Lancet 356 (9225), 247-250<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16567358615311863961" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:abG-DnoFyZgC" class="gsc_a_at">AN ASSESSMENT OF DEEP VENOUS FUNCTION FOLLOWING TOTAL HIP-ARTHROPLASTY COMPLICATED BY VENOGRAPHICALLY PROVEN DEEP-VEIN THROMBOSIS</a><div class="gs_gray">JA Skinner, DJ Gerrard, H Zahn, AT Cohen, MJL Porteous, EM Thomas</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 73 (6), 1110-1110<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3596486753171725341" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zUl2_INMlC4C" class="gsc_a_at">Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)</a><div class="gs_gray">N Picker, AY Lee, AT Cohen, A Maraveyas, J Beyer-Westendorf, ...</div><div class="gs_gray">Thrombosis and haemostasis 121 (02), 206-215<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4040602347649529767" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nqdriD65xNoC" class="gsc_a_at">Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised&nbsp;…</a><div class="gs_gray">NR Hill, C Arden, L Beresford-Hulme, AJ Camm, D Clifton, DW Davies, ...</div><div class="gs_gray">Contemporary clinical trials 99, 106191<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11965867351922054546" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Is there a role for low-dose DOACs as prophylaxis?</a><div class="gs_gray">AT Cohen, BJ Hunt</div><div class="gs_gray">Hematology 2014, the American Society of Hematology Education Program Book&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4602455987118723859" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients&nbsp;…</a><div class="gs_gray">V Laskier, H Guy, M Fisher, WR Neuman, I Bucior, AT Cohen, S Ren</div><div class="gs_gray">Journal of medical economics 22 (10), 1063-1072<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13730343266126285285" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Patient-reported outcomes associated with switching to rivaroxaban for the treatment of venous thromboembolism (VTE) in patients with active cancer</a><div class="gs_gray">AT Cohen, A Maraveyas, J Beyer-Westendorf, AYY Lee, LG Mantovani, ...</div><div class="gs_gray">Annals of Oncology 30, v724-v725<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8648367450550730197" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Improved benefit risk profile of rivaroxaban in a MARINER-like subpopulation of the MAGELLaN study</a><div class="gs_gray">AC Spyropoulos, AT Cohen, C Lipardi, J Xu, E Suh, Y De Sanctis, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A10541-A10541<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6475040697273172941" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use</a><div class="gs_gray">G Zoppellaro, N Veronese, S Granziera, L Gobbi, B Stubbs, AT Cohen</div><div class="gs_gray">Seminars in hematology 55 (4), 182-184<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6251719791991900955" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:isU91gLudPYC" class="gsc_a_at">Stenting Across the Inguinal Ligament in Post Thrombotic Syndrome Using Nitinol Venous Stents: One-year Patency Outcomes</a><div class="gs_gray">P Saha, AM Gwozdz, T El-Sayed, N Karunanithy, K Breen, BJ Hunt, ...</div><div class="gs_gray">European Journal of Vascular and Endovascular Surgery 54 (5), 664<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17501180757271904328" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hMsQuOkrut0C" class="gsc_a_at">The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?</a><div class="gs_gray">AT Cohen, S Granziera, N Veronese, G Zoppellaro</div><div class="gs_gray">Seminars in respiratory and critical care medicine 38 (01), 029-039<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7689629222597348067" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism</a><div class="gs_gray">C Browne, T Lanitis, M Hamilton, X Li, R Horbyluk, J Mardekian, ...</div><div class="gs_gray">Journal of medical economics 20 (1), 98-106<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7084629693939870455" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:DkZNVXde3BIC" class="gsc_a_at">IMPROVEDD score: addition of D-dimer to the IMPROVE score improves venous thromboembolism risk stratification. An APEX trial substudy</a><div class="gs_gray">CM Gibson, G Chi, P Jain, D Szlosek, SZ Goldhaber, RD Hull, ...</div><div class="gs_gray">Circulation 134 (suppl_1), A19875-A19875<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15582316537786047527" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:37UQlXuwjP4C" class="gsc_a_at">Hospitalizations, recurrent venous thromboembolism or venous thromboembolism-related death, and major bleeding, by index event from the AMPLIFY trial</a><div class="gs_gray">T Lee, C Masseria, A Breazna, G DiRusso, M Hamilton, R Horblyuk, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 2256-2256<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=303630526233999637" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">One-year clinical outcomes following deep venous reconstruction using dedicated venous stents</a><div class="gs_gray">P Saha, N Karunanithy, A Cohen, B Hunt, K Breen, S Black</div><div class="gs_gray">Journal of Vascular Surgery: Venous and Lymphatic Disorders 4 (1), 152<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13374333695378655726" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Clinical presentation, impact and course of major bleeding events with apixaban and warfarin: PO353-TUE</a><div class="gs_gray">S Bleker, A Cohen, H Büller, G Agnelli, A Gallus, G Raskob, J Weitz, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13, 635-636<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9056504298814011323" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eI34FqJmdUoC" class="gsc_a_at">Asynchronous symbol replacement system and method for game systems</a><div class="gs_gray">A Cohen, O Berg, T Niva</div><div class="gs_gray">US Patent App. 14/171,742<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9101321818946212903" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-95Q15plzcUC" class="gsc_a_at">Oral apixaban for the treatment of acute venous thromboembolism</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray">Journal of Vascular Surgery 59 (1), 269<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14712938252516439025" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Apixaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism: a randomized, double-blind trial (AMPLIFY): AS 12.2</a><div class="gs_gray">G Agnelli, H Buller, A Cohen, M Curto, A Gallus, M Johnson, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10622294037666041404" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">The efficacy and safety of pharmacological prophylaxis of VTE following elective knee or hip replacement: systematic review and network meta-analysis</a><div class="gs_gray">A Cohen, D Pieter, N Marchant, S Mitchell, M Orme, T Simon, A Sutton, ...</div><div class="gs_gray">Blood 118 (21), 2314<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12169989026905195778" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Venous thromboembolism (VTE) in cancer patients receiving chemotherapy: a real-world analysis of VTE risk and the impact of VTE on healthcare expenditure</a><div class="gs_gray">GH Lyman, Y Wang, H Wang, AT Cohen</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 47, S222-S222<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1530440610733146934" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Incidence of venous thromboembolism (VTE) in the general population-VTE epidemiology group (VEG) study: O-MO-095</a><div class="gs_gray">C Martinez, S Rietbrock, L Bamber, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10884861763792689036" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:6VlyvFCUEfcC" class="gsc_a_at">Epidemiologie de la fibrillation atriale en France: extrapolation a partir des donnees internationales et point sur les hospitalisations</a><div class="gs_gray">A Charlemagne, J Blacher, A Cohen, JP Collet, F Dievart, P de Groote, ...</div><div class="gs_gray">ARCHIVES OF CARDIOVASCULAR DISEASES 104 (2), 115-124<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16604740368559706873" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: MAGELLAN study methodology</a><div class="gs_gray">AT Cohen, TE Spiro, HR Büller, L Haskell, DY Hu, R Hull, A Mebazaa, ...</div><div class="gs_gray">Blood 116 (21), 3331<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1760798906149786191" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AHdEip9mkN0C" class="gsc_a_at">GRADUATED COMPRESSION STOCKINGS DO NOT ADD TO THE EFFICACY OF FONDAPARINUX FOR THROMBOPROPHYLAXIS IN HIP REPLACEMENT SURGERY. A MULTI-CENTRE, MULTI-NATIONAL, RANDOMISED, OPEN&nbsp;…</a><div class="gs_gray">A Cohen, I Brenkel, J Skinner, D Warwick</div><div class="gs_gray">Orthopaedic Proceedings 91 (SUPP_I), 73-73<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11810590551851432783" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">The use of graduated compression stockings in association with fondaparinux in surgery of the hip: a multicentre, multinational, randomised, open-label, parallel-group&nbsp;…</a><div class="gs_gray">A COHEN, J SKINNER, D Warwick, I Brenkel</div><div class="gs_gray">The Journal of Bone and Joint Surgery-british Volume 90 (11)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12818080823313279036" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wKETBy42zhYC" class="gsc_a_at">1123-181 Thromboprophylaxis with dalteparin reduces clinically important venous thromboembolism in patients with congestive heart failure</a><div class="gs_gray">AG Turpie, AT Cohen, CG Olsson, PT Vaitkus, SZ Goldhaber, ...</div><div class="gs_gray">Journal of the American College of Cardiology 43 (5S2), A501-A501<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13293374095294914506" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Ximelagatran, and its subcutaneous form melagatran, versus enoxaparin as thromboprophylaxis in total hip or total knee replacement</a><div class="gs_gray">F Peters, A Cohen, G Agnelli, O Dahl, B Eriksson, P Kälebo, M Lassen, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=729585099957549224" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:W5xh706n7nkC" class="gsc_a_at">LONG HAUL FLIGHTS AND DEEP VEIN THROMBOSIS: WHO IS AT RISK?</a><div class="gs_gray">R ARYA, A COHEN</div><div class="gs_gray">British Journal of Haematology 120 (2)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6338724508911766584" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">The oral direct thrombin inhibitor ximelagatran and its active form melagatran are efficacious and well tolerated as thromboprophylaxis after total hip or total knee&nbsp;…</a><div class="gs_gray">A Cohen, B Eriksson, G Agnelli, O Dahl, P Mouret, N Rosencher</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12122398772542591028" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement--The never-ending story?</a><div class="gs_gray">OE Dahl, D Bergqvist, AT Cohen, SP Frostick, RD Hull, BM Persson</div><div class="gs_gray">Acta Orthopaedica Scandinavica 72 (2), 199-204<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=668643341423622802" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Management of unstable coronary-artery disease</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">The Lancet 355 (9203), 574<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=48566144414593589" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Prevention of deep vein thrombosis after hip replacement</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Thrombosis and haemostasis 83 (01), 171-171<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10366732867931947606" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NMlhSUseqAsC" class="gsc_a_at"># 613 Self-reported initial management approaches for childhood idiopathic thrombocytopenic purpura (ITP): results of a survey of members of The American Society of Pediatric&nbsp;…</a><div class="gs_gray">GR Buchanan, S Vesely, G Raskob, A Cohen, J George</div><div class="gs_gray">Journal of Pediatric Hematology/Oncology 20 (4), 376<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18387983722801171393" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">The clinical experience of reviparin in the prevention of deep vein thrombosis</a><div class="gs_gray">AT Cohen, MS Mohamed, VV Kakkar</div><div class="gs_gray">DRUGS OF TODAY 31, 5-10<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15556039304605744469" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting</a><div class="gs_gray">NJM London, K Varty, M Thompson, RD Sayers, PRF Bell, VV Kakkar, ...</div><div class="gs_gray">The Lancet 344 (8936), 1571-1572<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13686325325115969757" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PyEswDtIyv0C" class="gsc_a_at">A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING A NEW LOW-MOLECULAR-WEIGHT HEPARIN (LMWH, LU47311-CLIVARINE (TM)) AND UNFRACTIONATED HEPARIN (UFH) IN PREVENTION OF DEEP&nbsp;…</a><div class="gs_gray">VV Kakkar, B Boneu, AT Cohen, M SUJJATA</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 651-651<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14560176027312348601" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QsKbpXNoaWkC" class="gsc_a_at">Double trouble for cancer patients</a><div class="gs_gray">AT Cohen, IM Bistervels</div><div class="gs_gray">European Heart Journal<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=175475294432621879" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:pYKElYtJMmwC" class="gsc_a_at">Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY</a><div class="gs_gray">AT Cohen, S Pan, W Byon, BS Ilyas, T Taylor, TC Lee</div><div class="gs_gray">Advances in Therapy, 1-16<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16350718708372527674" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:9DLIHnF0jcYC" class="gsc_a_at">Recommendations for Research Assessing Outcomes for Patients With Anticoagulant-Related Intracerebral Bleeds</a><div class="gs_gray">M Concha, AT Cohen</div><div class="gs_gray">Stroke 52 (4), 1520-1526<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4114673885432387105" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:s85pQhAUCrAC" class="gsc_a_at">ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months</a><div class="gs_gray">G Agnelli, U Hoffmann, P Hainaut, S Gaine, C Ay, M Coppens, ...</div><div class="gs_gray">Thrombosis research 196, 297-304<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9233709220457538305" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Incidence and risk of venous thromboembolic events among patients with rheumatoid arthritis enrolled in the Upadacitinib clinical trial program</a><div class="gs_gray">E Choy, I McInnes, J Cush, J Aelion, W Rigby, Y Song, S Meerwein, J Liu, ...</div><div class="gs_gray">ARTHRITIS &amp; RHEUMATOLOGY 72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8949727131228910990" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:M7yex6snE4oC" class="gsc_a_at">Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom</a><div class="gs_gray">H Guy, V Laskier, M Fisher, I Bucior, S Deitelzweig, AT Cohen</div><div class="gs_gray">Expert review of pharmacoeconomics &amp; outcomes research 20 (3), 259-267<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6002083594395405819" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Derivation and Validation of a Prediction Model for Venous Thromboembolism in Primary Care</a><div class="gs_gray">F Dentali, A Fontanella, AT Cohen, M Simonetti, L Parretti, E Marconi, ...</div><div class="gs_gray">Thrombosis and haemostasis 120 (04), 692-701<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4035280975240577407" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial</a><div class="gs_gray">AC Spyropoulos, GE Raskob, AT Cohen, W Ageno, JI Weitz, TE Spiro, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=759109289639586577" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:DXE8ND7PrJAC" class="gsc_a_at">Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du&nbsp;…</a><div class="gs_gray">A Godier, D Garrigue, D Lasne, P Fontana, F Bonhomme, JP Collet, ...</div><div class="gs_gray">Anesthésie &amp; Réanimation 5 (3), 218-237<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4994953608323935857" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Characterization of major and clinically relevant non-major bleeds in the APEX trial</a><div class="gs_gray">MK Yee, CM Gibson, T Nafee, M Kerneis, Y Daaboul, S Korjian, G Chi, ...</div><div class="gs_gray">TH Open 3 (02), e103-e108<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18068156950540553541" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:7Frjd3zlGBUC" class="gsc_a_at">PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL</a><div class="gs_gray">AK Karabay, CM Gibson, G Chi, F Alkhalfan, A Pitliya, SS Walia, T Nafee, ...</div><div class="gs_gray">Journal of the American College of Cardiology 73 (9S1), 1944-1944<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9762503540875098789" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:jFemdcug13IC" class="gsc_a_at">Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE&nbsp;…</a><div class="gs_gray">AT Cohen, C Ay, P Hainaut, H Décousus, U Hoffmann, S Gaine, ...</div><div class="gs_gray">Thrombosis journal 16 (1), 1-1<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14021188386885483703" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">4321 Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial</a><div class="gs_gray">G Chi, CM Gibson, AF Hernandez, RD Hull, AT Cohen, RA Harrington, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy563. 4321<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9008800331481454181" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial</a><div class="gs_gray">G Chi, CM Gibson, AF Hernandez, RD Hull, AT Cohen, RA Harrington, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 868-868<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4079717355279588716" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Extended Thromboprophylaxis With Betrixaban Is Cost-Effective In Acutely ILL Medical Patients</a><div class="gs_gray">W Huang, F Anderson, I Bucior, WR Neuman, AT Cohen</div><div class="gs_gray">Value in Health 21, S61<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17329125928453767221" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EkHepimYqZsC" class="gsc_a_at">Betrixaban Reduces Not Only the Presence of Thrombus but Also Extent of Thrombus: An APEX Trial Substudy</a><div class="gs_gray">G Chi, T Nafee, SZ Goldhaber, AF Hernandez, RD Hull, A Gold, S Korjian, ...</div><div class="gs_gray">Circulation 136 (suppl_1), A20444-A20444<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7264453042230250056" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy</a><div class="gs_gray">G Chi, T Nafee, SZ Goldhaber, AF Hernandez, RD Hull, A Gold, S Korjian, ...</div><div class="gs_gray">Circulation 136 (suppl_1), A20322-A20322<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2385064116173168719" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AYInfyleIOsC" class="gsc_a_at">Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study</a><div class="gs_gray">JM Leeds, DR Wada, O Bandman, A Gold, AT Cohen, JT Curnutte, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 1063-1064<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17768066430746440754" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic&nbsp;…</a><div class="gs_gray">AT Cohen, M Hamilton, A Bird, SA Mitchell, X Li, R Horblyuk, S Batson</div><div class="gs_gray">Plos one 11 (9), e0163386<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15202440281608935146" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qUcmZB5y_30C" class="gsc_a_at">VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban-A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended&nbsp;…</a><div class="gs_gray">C Gibson, R Harrington, S Goldhaber, A Hernandez, R Hull, B Wiens, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14, 8-9<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1722642486986554190" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients</a><div class="gs_gray">N Kraaijpoel, N van Es, SM Bleker, MP Brekelmans, ES Eerenberg, ...</div><div class="gs_gray">Blood 128 (22), 2611<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10337512487361439098" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis: reply</a><div class="gs_gray">N Veronese, G Bano, S Granziera, M Solmi, AT Cohen, CU Correll</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14 (1), 221-223<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8099777069385150801" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Potential clinical benefits and cost savings associated with inclusion of apixaban in the formulary for treatment of patients with venous thromboembolism</a><div class="gs_gray">M Hamilton, R Leipold, D Rublee, S Stern, D Gabriel, T Gosden, A Cohen</div><div class="gs_gray">European heart journal 36, 225-225<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5471433215353126999" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Apixaban for treatment of venous thromboembolism in patients from study centres in Asia; a subgroup analysis of the amplify trial: PO608-TUE</a><div class="gs_gray">A Gallus, G Agnelli, H Buller, A Cohen, T Lee, R Pak, G Raskob, H Shi, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6084817715640350202" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Long-term anticoagulation with rivaroxaban for the prevention of recurrent deep venous thrombosis and pulmonary embolism: a benefit-risk analysis on the EINSTEIN EXTENSION&nbsp;…</a><div class="gs_gray">P Wells, M Prins, B Levitan, Z Yuan, E Katz, J Beyer-Westendorf, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2347967065766920733" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Readmittance to hospital within 6 months after a venous thromboembolism event: PREFER in VTE registry</a><div class="gs_gray">R Bauersachs, AK Gitt, P Mismetti, M Monreal, SN Willich, WP Wolf, ...</div><div class="gs_gray">Value in Health 17 (7), A472-A473<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=967716132836020666" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Analysis of the bleeding and thromboembolic risk with concomitant use of antiplatelet treatment in the AMPLIFY trial</a><div class="gs_gray">A Cohen, G Agnelli, HR Buller, S Chaudhuri, AS Gallus, GE Raskob, ...</div><div class="gs_gray">Canadian Journal of Cardiology 30 (10), S272<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5632499223259260232" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Comparison of apixaban, dabigatran and rivaroxaban in the acute treatment and prevention of venous thromboembolism: Systematic review and network meta-analysis</a><div class="gs_gray">A Cohen, H Fowler, M Hamilton, H Phatak, SA Mitchell, XC Liu, A Claflin, ...</div><div class="gs_gray">European Heart Journal 35, 1064-1064<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13625257821100725486" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Cost-effectiveness of apixaban compared to other anticoagulants for the acute (6-month) treatment of venous thromboembolism</a><div class="gs_gray">T Lanitis, R Leipold, M Hamilton, D Rublee, P Quon, C Browne, A Cohen</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 1064-1064<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2676436308314135642" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">AMPLIFY-EXT: apixaban for prevention of venous thromboembolism</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray">N Engl J Med 368, 699-708<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10579973864074584000" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Risk of Major Bleeding in Cancer Patients Receiving Chemotherapy</a><div class="gs_gray">JH Zong, L Eckert, L Zhang, WS Dai, AT Cohen, GH Lyman</div><div class="gs_gray">Annals of Oncology 23, ix447<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12475805392909365936" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Prevention of VTE in women with cancer</a><div class="gs_gray">AT Cohen, JO Wills, N Bharathi, JV Solis</div><div class="gs_gray">Thrombosis research 127, S5-S8<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13504155300207220023" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0CzhzZyukY4C" class="gsc_a_at">3002 POSTER DISCUSSION Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure</a><div class="gs_gray">GH Lyman, Y Wang, H Wang, AT Cohen</div><div class="gs_gray">European Journal of Cancer, S222<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11981274952377008134" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">The Magellan Study Methodology: Rivaroxaban Compared With Enoxaparin For The Prevention Of Venous Thromboembolism In Hospitalized Medically Ill Patients</a><div class="gs_gray">T Cohen, T Spiro, H Bueller, W Byra, D Hu, R Hull, A Mebazza, G Merli, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 66-67<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9631514105484458501" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Venous Thromboembolism Risk and Prophylaxis Practices in Surgical Patients with Active Cancer: Findings from the Global ENDORSE Survey.</a><div class="gs_gray">AK Kakkar, AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, ...</div><div class="gs_gray">Blood 112 (11), 984<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5981902547668836337" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? Yes</a><div class="gs_gray">AT Cohen, LMA Maillardet</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 4 (10), 2130-2132<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6916829203929435555" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Overview of current practice and future trends in thromboprophylaxis for general surgery</a><div class="gs_gray">C Hee, A Singh, F Tudor, K Akinola, AT Cohen</div><div class="gs_gray">Vascular Disease Prevention 2 (4), 311-315<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16731575773709619223" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Thromboprophylaxis With Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Respiratory Failur</a><div class="gs_gray">AT Cohen, A Leizorovicz, AG Turpie, CG Olsson, PT Vaitkus, ...</div><div class="gs_gray">Chest 124 (4), 132S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7484110548880577045" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Prevalence of DVT in the operated and nonoperated limb following hip arthroplasty</a><div class="gs_gray">I Osborne, R Alikhan, P Vaughan, H Zaw, A Cohen</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 24-25<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17132215725129653952" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">Prevention of venous thromboembolism in medical patients: a meta-analysis of the clinical trials</a><div class="gs_gray">R Alikhan, P Vaughan, R Wilmott, I Osborne, J Gardner, A Cohen</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15546661719308803663" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:olpn-zPbct0C" class="gsc_a_at">Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer</a><div class="gs_gray">D Bergovist, G Agnelli, AT Cohen, ENOXACAN II Investigators</div><div class="gs_gray">ACC Current Journal Review 5 (11), 31-32<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5113538406926719942" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Extended thromboprophylaxis with low molecular weight heparin reduces venous thromboembolism following major general surgery-A meta-analysis.</a><div class="gs_gray">AT Cohen, R Alikhan, H Zaw, P Vaughan, R Al-Ghnaniem, D Cooper</div><div class="gs_gray">Blood 98 (11), 267A-267A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1512886421037382573" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty</a><div class="gs_gray">R Alikhan, AT Cohen</div><div class="gs_gray">The Journal of bone and joint surgery. British volume 83 (3), 460-460<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2679995735778471211" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Prophylaxis of venous thromboembolism in acute medical patients with enoxaparin: An international, randomized, double-blind, placebo-controlled trial</a><div class="gs_gray">MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 685-685<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7381869515439484193" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tYavs44e6CUC" class="gsc_a_at">Thrombin inhibitors in intimal hyperplasia</a><div class="gs_gray">DJ Gerrard, RA Edmondson, NV Wilson, AT Cohen, MJ Phillips, ...</div><div class="gs_gray">BRITISH JOURNAL OF SURGERY 81 (12), 1801-1801<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7743898239024850630" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QoJ_w57xiyAC" class="gsc_a_at">Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism–The COSIMO study</a><div class="gs_gray">AT Cohen, A Maraveyas, J Beyer-Westendorf, AYY Lee, K Folkerts, ...</div><div class="gs_gray">Thrombosis Research 206, 1-4<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:oTdOBqtIf_kC" class="gsc_a_at">Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative&nbsp;…</a><div class="gs_gray">A Godon, CA Tacquard, A Mansour, D Garrigue, P Nguyen, D Lasne, ...</div><div class="gs_gray">Anaesthesia, critical care &amp; pain medicine<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EaFouW7jFu4C" class="gsc_a_at">Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study</a><div class="gs_gray">M Giustozzi, JM Connors, AB Ruperez Blanco, S Szmit, N Falvo, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:cBPnxVikjH8C" class="gsc_a_at">Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY</a><div class="gs_gray">AT Cohen, S Pan, W Byon, BS Ilyas, T Taylor, TC Lee</div><div class="gs_gray">Advances in Therapy, 1-2<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:M0leSnx2MbUC" class="gsc_a_at">Iron deficiency in chronic myocarditis: Assessment and prognostic significance</a><div class="gs_gray">G Peretto, S Sala, C Camaschella</div><div class="gs_gray">European Journal of Internal Medicine 89, 129-131<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hNSvKAmkeYkC" class="gsc_a_at">Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights&nbsp;…</a><div class="gs_gray">M Giustozzi, L Valerio, G Agnelli, C Becattini, EM Fronk, FA Klok, ...</div><div class="gs_gray">European journal of internal medicine 88, 43-51<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:orDZ08hpP44C" class="gsc_a_at">Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer</a><div class="gs_gray">AT Cohen, A Keshishian, T Lee, L Rosenblatt, P Hlavacek, J Sah, X Luo</div><div class="gs_gray">Current medical research and opinion, 1-1<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">ANDEXANET ALFA FOR ACUTE BLEEDING DURING TREATMENT WITH ENOXAPARIN</a><div class="gs_gray">TF van Haaps, AP Benz, L Xu, M Coppens, JW Eikelboom, TJ Milling Jr, ...</div><div class="gs_gray">Journal of the American College of Cardiology 77 (18_Supplement_1), 1856-1856<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QVtou7C4vgoC" class="gsc_a_at">Direct oral anticoagulant plasma concentrations in obese and high body weight patients: An observational study</a><div class="gs_gray">A Martin, W Thomas, Z Mahir, MP Crowley, T Dowling, K Breen, ...</div><div class="gs_gray">Archives of Cardiovascular Diseases Supplements 13 (1), 164<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:c_xDhezhKKUC" class="gsc_a_at">The effect of thrombophilia on the clinical outcomes of chronic post-thrombotic patients following ilio-femoral stenting with nitinol venous stents.</a><div class="gs_gray">AM Gwozdz, AJ Doyle, BJ Hunt, LG Tincknell, N Jackson, P Saha, ...</div><div class="gs_gray">Journal of Vascular surgery. Venous and Lymphatic Disorders<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nPTYJWkExTIC" class="gsc_a_at">Effectiveness and Safety of Apixaban Vs Warfarin Among Venous Thromboembolism Patients Using Five US Databases: A Subgroup Analysis of Obesity</a><div class="gs_gray">AT Cohen, J Sah, T Lee, G Wygant, L Rosenblatt, P Hlavacek, B Emir, ...</div><div class="gs_gray">Blood 136, 1<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis</a><div class="gs_gray">B van Hout, E Hawe, AT Cohen</div><div class="gs_gray">TH Open 4 (03), e245-e254<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YB4bud6kWLwC" class="gsc_a_at">Recommended Reading from the Pulmonology Department, Institut universitaire de cardiologie et de pneumologie de Québec, affiliated to Université Laval.</a><div class="gs_gray">MH Denault, LV Morin-Thibault, SB Kermelly, C Labbé</div><div class="gs_gray">American journal of respiratory and critical care medicine<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients</a><div class="gs_gray">C Martinez, A Katholing, C Wallenhorst, AT Cohen</div><div class="gs_gray">British journal of haematology 189 (3), 524-533<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:JWITY9-sCbMC" class="gsc_a_at">Association Between Index VTE Event and 12-Months Outcomes for Patients in Routine Clinical Practice Enrolled in the ETNA-VTE-Europe Registry</a><div class="gs_gray">M Coppens, AT Cohen, C Ay, P Hainaut, U Hoffmann, S Gaine, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban</a><div class="gs_gray">M Schindewolf, B Brüggenjürgen, C Ay, P Hainaut, U Hoffmann, S Gaine, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hQUaER0FWQ4C" class="gsc_a_at">ETNA VTE Europe: A contemporary snapshot of VTE patients treated with edoxaban in clinical practice across eight European countries</a><div class="gs_gray">AT Cohen, U Hoffmann, P Hainaut, S Gaine, C Ay, M Coppens, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">Association between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolled in the Edoxaban Treatment in routine&nbsp;…</a><div class="gs_gray">M Coppens, AT Cohen, C Ay, P Hainaut, U Hoffmann, S Gaine, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:umqufdRvDiIC" class="gsc_a_at">Response to" Letter to the Editor concerning:'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and&nbsp;…</a><div class="gs_gray">AT Cohen, NR Hill, X Luo, C Masseria, SA Abariga, AO Ashaye</div><div class="gs_gray">International journal of cardiology 306, 101-101<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis-Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial</a><div class="gs_gray">A Maraveyas, J Beyer-Westendorf, AYY Lee, LG Mantovani, Y De Sanctis, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale</a><div class="gs_gray">AT Cohen, A Keshishian, T Lee, G Wygant, L Rosenblatt, P Hlavacek, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies</a><div class="gs_gray">AC Spyropoulos, C Lipardi, AT Cohen, B Vučković, J Xu, W Lu, TE Spiro, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study</a><div class="gs_gray">V Ten Cate, AWA Lensing, JI Weitz, J Beyer-Westendorf, PS Wells, ...</div><div class="gs_gray">haematologica 104 (10), e474<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study</a><div class="gs_gray">J Beyer-Westendorf, P Yue, M Crowther, JW Eikelboom, CM Gibson, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 40, 94-94<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">288 Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study</a><div class="gs_gray">J Beyer-Westendorf, P Yue, M Crowther, JW Eikelboom, CM Gibson, ...</div><div class="gs_gray">European Heart Journal 40 (Supplement_1), ehz747. 0092<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design</a><div class="gs_gray">PE Reimitz, Y Koretsune, C Chen, U Thee, J Kaburagi, YH Kim, WI Choi, ...</div><div class="gs_gray">School of Medicine (의과대학) 42 (12)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Andexanet alfa for treatment of factor Xa inhibitor-related acute major bleeding</a><div class="gs_gray">T Fralich, TJ Milling, SJ Connolly, J Eikelboom, CM Gibson, PB Conley, ...</div><div class="gs_gray">Journal Of Thrombosis And Thrombolysis 47 (4), 608-608<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">An adaptive-design dose-ranging study of PD 0348292, an oral Xa inhibitor for thromboprophylaxis after total knee replacement surgery (vol 11, pg 1503, 2013)</a><div class="gs_gray">AT Cohen, RA Boyd, JW Mandema, L DiCarlo, R Pak</div><div class="gs_gray">JOURNAL OF THROMBOSIS AND HAEMOSTASIS 16 (12), 2541-2541<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner&nbsp;…</a><div class="gs_gray">JI Weitz, GE Raskob, AC Spyropoulos, AT Cohen, TE Spiro, Y De Sanctis, ...</div><div class="gs_gray">Blood 132, 1236<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">Incidence, Prevalence, Characteristics, and Outcomes in Patients With Newly-Diagnosed Coronary Artery Disease or Peripheral Artery Disease in Real-World Population of the&nbsp;…</a><div class="gs_gray">GC Fonarow, DY Teltsch, A Cohen, J Cleland, E Cheever, M Gierada, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16575-A16575<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Hypoalbuminemia and Its Association With Venous Thromboembolism in Acutely Ill Hospitalized Patients: Findings From the APEX Trial</a><div class="gs_gray">G Chi, M Gibson, AF Hernandez, RD Hull, AT Cohen, RA Harrington, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16347-A16347<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Predictors of the Risk of Community-Acquired Major Bleeding and Non-Major Bleeding Requiring Hospitalization in First Venous Thromboembolism Treated With Vitamin K Antagonists&nbsp;…</a><div class="gs_gray">GD Wygant, C Martinez, C Wallenhorst, A Katholing, AT Cohen</div><div class="gs_gray">Circulation 138 (Suppl_1), A13071-A13071<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Prognostic Value of C-Reactive Protein as Inflammatory Marker for Venous Thromboembolism in Acutely Ill Hospitalized Patients: Analysis From the APEX Trial</a><div class="gs_gray">G Chi, M Gibson, AF Hernandez, RD Hull, AT Cohen, RA Harrington, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16125-A16125<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Betrixaban Reduced the Occurrence of Major Adverse Cardiovascular Events Among Acute Medically Ill Patients With a History of Myocardial Infarction or Stroke: Insights From the&nbsp;…</a><div class="gs_gray">TO Nafee, CM Gibson, MK Yee, M Kerneis, R Travis, F AlKhalfan, G Chi, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16280-A16280<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in US Clinical Practice</a><div class="gs_gray">D Weycker, X Li, GDV Wygant, T Lee, M Hamilton, X Luo, L Vo, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (11), e1-e2<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:uVUOdF_882EC" class="gsc_a_at">Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial</a><div class="gs_gray">T Nafee, CM Gibson, R Travis, M Kerneis, MK Yee, F Alkhalfan, G Chi, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 431-431<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial</a><div class="gs_gray">A Kalayci, CM Gibson, G Chi, M Yee, S Korjian, S Datta, T Nafee, M Gurin, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 31-32<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">P1623 Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial</a><div class="gs_gray">G Chi, CM Gibson, AF Hernandez, RD Hull, A Kalayci, M Kerneis, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy565. P1623<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">P251 Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial</a><div class="gs_gray">A Kalayci, CM Gibson, G Chi, M Yee, S Korjian, S Datta, T Nafee, M Gurin, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy564. P251<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">P6072 Characterization of major and clinically relevant non-major bleeding in the APEX trial</a><div class="gs_gray">T Nafee, CM Gibson, MK Yee, R Travis, M Kerneis, G Chi, F Alkhalfan, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy566. P6072<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:cWzG1nlazyYC" class="gsc_a_at">109 Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis</a><div class="gs_gray">MK Yee, CM Gibson, T Nafee, M Kerneis, R Travis, F Alkhalfan, G Chi, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy564. 109<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial</a><div class="gs_gray">G Chi, CM Gibson, AF Hernandez, RD Hull, A Kalayci, M Kerneis, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 318-318<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:bnK-pcrLprsC" class="gsc_a_at">2160 Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial</a><div class="gs_gray">T Nafee, CM Gibson, R Travis, M Kerneis, MK Yee, F Alkhalfan, G Chi, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy565. 2160<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:a0OBvERweLwC" class="gsc_a_at">Characterization of major and clinically relevant non-major bleeding in the APEX trial</a><div class="gs_gray">T Nafee, CM Gibson, MK Yee, R Travis, M Kerneis, G Chi, F Alkhalfan, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 1264-1265<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis</a><div class="gs_gray">MK Yee, CM Gibson, T Nafee, M Kerneis, R Travis, F Alkhalfan, G Chi, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 7-8<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4Yq6kJLCcecC" class="gsc_a_at">Mapping Pemb-Qol to Generic EQ-5D-5L in Patients with Pulmonary Embolism, a Cross-Walk Study</a><div class="gs_gray">LH Chuang, S Kroep, P Gumbs, JM Rodriguez, A Cohen, B Van Hout</div><div class="gs_gray">17th Biennial European Conference<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Extended Thromboprophylaxis With Betrixaban is Cost-effective in Acutely Ill Medical Patients</a><div class="gs_gray">H Wei, FA Anderson, I Bucior, WR Neuman, AT Cohen</div><div class="gs_gray">Circulation: Cardiovascular Quality and Outcomes 11 (suppl_1), A135-A135<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">State of play and future direction with NOACs</a><div class="gs_gray">AT Cohen, G Lip, R De Caterina, H Heidbuchel, JL Zamorano, G Agnelli, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Burden Of Illness Of Pulmonary Embolism In Europe–Healthcare Resource Utilization And Productivity Loss</a><div class="gs_gray">SN Willich, L Chuang, B van Hout, G Agnelli, PD Gumbs, R Bauersachs, ...</div><div class="gs_gray">Value in Health 20 (9), A611<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Burden Of Illness Of Deep Vein Thrombosis In Europe–Mortality And Health Related Quality Of Life</a><div class="gs_gray">M Monreal, G Agnelli, L Chuang, AT Cohen, PD Gumbs, R Bauersachs, ...</div><div class="gs_gray">Value in Health 20 (9), A611<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Burden Of Illness Of Deep-Vein Thrombosis In Europe–Healthcare Resource Utilization And Productivity Loss</a><div class="gs_gray">L Chuang, B van Hout, AT Cohen, PD Gumbs, S Kroep, M Monreal, ...</div><div class="gs_gray">Value in Health 20 (9), A612<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis</a><div class="gs_gray">L Chuang, AT Cohen, G Agnelli, PD Gumbs, R Bauersachs, S Kroep, ...</div><div class="gs_gray">Value in Health 20 (9), A623<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Burden Of Illness Of Pulmonary Embolism In Europe–Mortality And Health Related Quality Of Life</a><div class="gs_gray">L Chuang, PD Gumbs, B van Hout, G Agnelli, AT Cohen, R Bauersachs, ...</div><div class="gs_gray">Value in Health 20 (9), A611<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">The Impact Of Co-Morbidity On The Disease Burden Of VTE</a><div class="gs_gray">S Kroep, L Chuang, B van Hout, G Agnelli, PD Gumbs, AK Gitt, M Monreal, ...</div><div class="gs_gray">Value in Health 20 (9), A601<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose&nbsp;…</a><div class="gs_gray">CM Gibson, DF Arbetter, P Jain, R Halaby, G Chi, T Nafee, S Korjian, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 382-382<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:rbm3iO8VlycC" class="gsc_a_at">P1732Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose&nbsp;…</a><div class="gs_gray">CM Gibson, DF Arbetter, P Jain, R Halaby, G Chi, T Nafee, S Korjian, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SGW5VrABaM0C" class="gsc_a_at">New onset dementia in incident atrial fibrillation. A large cohort study</a><div class="gs_gray">B Weijs, TS Field, A Curcio, M Giustozzi, S Sudikas, A Katholing, JI Weitz, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 983-983<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Lifestyle risk factors for non-valvular atrial fibrillation</a><div class="gs_gray">CA Buzea, L Pagliani, T Gregorio, M Santos, R Providencia, JI Weitz, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 239-239<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">P5600History of venous thromboembolism is associated with higher risk for recurrent venous thromboembolism: insights from the APEX trial</a><div class="gs_gray">MK Yee, G Chi, T Nafee, S Korjian, Y Daaboul, RA Harrington, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">History of venous thromboembolism is associated with higher risk for recurrent venous thromboembolism: insights from the APEX trial</a><div class="gs_gray">MK Yee, G Chi, T Nafee, S Korjian, Y Daaboul, RA Harrington, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 1205-1205<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ODE9OILHJdcC" class="gsc_a_at">P5136Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study</a><div class="gs_gray">JM Leeds, DR Wada, O Bandman, A Gold, AT Cohen, JT Curnutte, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">P1551D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely Ill medical patients&nbsp;…</a><div class="gs_gray">CM Gibson, DF Arbetter, P Jain, R Halaby, G Chi, T Nafee, S Korjian, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">P4624New onset dementia in incident atrial fibrillation. A large cohort study</a><div class="gs_gray">B Weijs, TS Field, A Curcio, M Giustozzi, S Sudikas, A Katholing, JI Weitz, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ye4kPcJQO24C" class="gsc_a_at">1190Lifestyle risk factors for non-valvular atrial fibrillation</a><div class="gs_gray">CA Buzea, L Pagliani, T Gregorio, M Santos, R Providencia, JI Weitz, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:u9iWguZQMMsC" class="gsc_a_at">P4316N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with stroke among hospitalized medical patients: an APEX trial substudy</a><div class="gs_gray">G Chi, T Nafee, S Korjian, Y Daaboul, RA Harrington, SZ Goldhaber, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NhqRSupF_l8C" class="gsc_a_at">P5599Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis</a><div class="gs_gray">G Chi, T Nafee, S Korjian, Y Daaboul, RA Harrington, SZ Goldhaber, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0EnyYjriUFMC" class="gsc_a_at">D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely III medical patients: insights&nbsp;…</a><div class="gs_gray">CM Gibson, DF Arbetter, P Jain, R Halaby, G Chi, T Nafee, S Korjian, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 326-326<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with stroke among hospitalized medical patients: an APEX trial substudy</a><div class="gs_gray">G Chi, T Nafee, S Korjian, Y Daaboul, RA Harrington, SZ Goldhaber, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 38, 886-886<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:unp9ATQDT5gC" class="gsc_a_at">ESTIMATED ANNUAL NUMBER OF US ACUTE-CARE HOSPITAL INPATIENTS MEETING ACCP CRITERIA FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS</a><div class="gs_gray">W Huang, AT Cohen, M Zayaruzny, A Wyman, F Anderson</div><div class="gs_gray">VALUE IN HEALTH 20 (5), A279-A279<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5. 059)</a><div class="gs_gray">SJ Connolly, TJ Milling, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...</div><div class="gs_gray">Neurology 88 (16 Supplement)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">LMWH FOR VTE PROPHYLAXIS: THE MEDENOX TRIAL Amy O. Flaster A Comparison of Enoxaparin With Placebo for the Prevention</a><div class="gs_gray">MM Samama, AT Cohen, JY Darmon</div><div class="gs_gray">Internal Medicine Evidence<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">ジャーナルクラブ</a><div class="gs_gray">JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ...</div><div class="gs_gray">N Engl J Med 376, 1211-1222<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Extended Duration Betrixaban Reduces the Risk of Stroke vs Standard Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Substudy</a><div class="gs_gray">CM Gibson, Y Daaboul, S Korjian, D Szolsek, P Jain, G Chi, A Hernandez, ...</div><div class="gs_gray">Circulation 134 (suppl_1), A19208-A19208<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Cost-Effectiveness of Edoxaban Compared to Warfarin for The Treatment and Secondary Prevention of Venous Thromboembolism in The UK</a><div class="gs_gray">E Clay, A Jamotte, AT Cohen, B van Hout, PD Gumbs, P Verhamme</div><div class="gs_gray">Value in Health 19 (7), A653-A654<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">An Analysis of the Efficacy and Safety of Edoxaban in Comparison with Rivaroxaban in the Treatment of Deep Vein Thrombosis and Pulmonary Embolism</a><div class="gs_gray">B van Hout, PD Gumbs, AT Cohen, P Verhamme</div><div class="gs_gray">Value in Health 19 (7), A637-A638<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">The Economic Burden of Pulmonary Embolism in Europe</a><div class="gs_gray">PD Gumbs, LLH Chuang, AT Cohen, G Agnelli, SN Willich, M Monreal, ...</div><div class="gs_gray">Value in Health 19 (7), A365<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient&nbsp;…</a><div class="gs_gray">MPA Brekelmans, SM Bleker, ES Eerenberg, AT Cohen, S Middeldorp, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 394-394<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Costs of major adverse outcomes in patients with incident venous thromboembolism in clinical practice in the United Kingdom</a><div class="gs_gray">AT Cohen, C Wallenhorst, S Rietbrock, M Hamilton, C Martinez</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 819-819<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:maZDTaKrznsC" class="gsc_a_at">Management of acute venous thromboembolism in Europe-follow-up data at 1 month from the PREFER in VTE registry</a><div class="gs_gray">R Bauersachs, G Agnelli, AK Gitt, P Laeis, P Mismetti, M Monreal, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 1223-1223<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Clinical Events Avoided with Apixaban Compared to Edoxaban for the Initial Treatment and Prevention of Venous Thromboembolism</a><div class="gs_gray">T Lanitis, M Hamilton, P Quon, C Browne, A Cohen</div><div class="gs_gray">Value in Health 19 (3), A48<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wSy_KLzO7YEC" class="gsc_a_at">A comparison of cancer types and the epidemiology of first venous thromboembolism in patients with active disease: HEM05</a><div class="gs_gray">A Cohen, A Katholing, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14, 76-77<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Acute venous thromboembolism in clinical practice-baseline bleeding risk results from the European PREFER in VTE registry: PRE13</a><div class="gs_gray">A Cohen, A Gitt, R Bauersachs, EM Fronk, P Laeis, P Mismetti, M Monreal, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Choosing wisely: the impact of inclusion and exclusion criteria on efficacy and safety outcomes in EINSTEINDVT/PE and AMPLIFY: CA06</a><div class="gs_gray">J Beyer-Westendorf, A Lensing, A Cohen, P Wells, M Prins</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 14<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wUn16MOA3RoC" class="gsc_a_at">King’s Research Portal</a><div class="gs_gray">J Beyer-Westendorf, AWA Lensing, R Arya, H Bounameaux, AT Cohen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Kommentar zu: Andexanet alfa als Antidot bei schwerwiegenden Blutungen unter Faktor Xa-Inhibitoren</a><div class="gs_gray">SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Vitamin K antagonist use and fracture risk: results from a systematic review and meta-analysis (vol 13, pg 1665, 2015)</a><div class="gs_gray">N Veronese, G Bano, G Bertozzo, S Granziera, M Solmi, E Manzato, ...</div><div class="gs_gray">JOURNAL OF THROMBOSIS AND HAEMOSTASIS 14 (1), 226-226<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial</a><div class="gs_gray">AT Cohen, R Halaby, S Korjian, Y Daaboul, D Szlosek, D Arbetter, ...</div><div class="gs_gray">Blood 128 (22), 3824<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Predictors of Major Bleeding in Patients with First Venous Thromboembolism Treated with Vitamin K Antagonists in Clinical Practice in the United Kingdom</a><div class="gs_gray">AT Cohen, C Wallenhorst, A Katholing, M Hamilton, S Unniachan, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 2327-2327<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Early Outcomes Following Endoluminal Deep Venous Reconstruction Using Dedicated Venous Stents</a><div class="gs_gray">P Saha, SA Black, A Cohen, N Karunanithy, BJ Hunt, K Breen</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 4721-4721<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Embedded qualitative study</a><div class="gs_gray">SI Noble, A Nelson, D Fitzmaurice, MJ Bekkers, J Baillie, S Sivell, ...</div><div class="gs_gray">A feasibility study to inform the design of a randomised controlled trial to&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Overall discussion and conclusions</a><div class="gs_gray">SI Noble, A Nelson, D Fitzmaurice, MJ Bekkers, J Baillie, S Sivell, ...</div><div class="gs_gray">A feasibility study to inform the design of a randomised controlled trial to&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">The ALICAT randomised controlled trial</a><div class="gs_gray">SI Noble, A Nelson, D Fitzmaurice, MJ Bekkers, J Baillie, S Sivell, ...</div><div class="gs_gray">A feasibility study to inform the design of a randomised controlled trial to&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Patient pathways</a><div class="gs_gray">SI Noble, A Nelson, D Fitzmaurice, MJ Bekkers, J Baillie, S Sivell, ...</div><div class="gs_gray">A feasibility study to inform the design of a randomised controlled trial to&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AZju0d2GQJ0C" class="gsc_a_at">Mortality following venous thromboembolism: a population-based cohort study in patients with active cancer: PO124-TUE</a><div class="gs_gray">C Martinez, A Katholing, S Rietbrock, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:yY3RG6sOEgwC" class="gsc_a_at">Risk of recurrent venous thromboembolism in patients with active cancer: AS084</a><div class="gs_gray">A Cohen, S Rietbrock, A Katholing, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Epidemiology of first venous thromboembolism in patients with active cancer: OR294</a><div class="gs_gray">A Cohen, A Katholing, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Clinical impact and course of major bleeding with edoxaban vs. vitamin K antagonists: OR199</a><div class="gs_gray">M Brekelmans, S Bleker, R Bauersachs, Z Boda, H Büller, Y Choi, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13, 170-171<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Clinical presentation and extent of clinical care of clinically relevant non-major bleeding events with apixaban and warfarin: PO409-WED</a><div class="gs_gray">S Bleker, A Cohen, H Büller, G Agnelli, A Gallus, G Raskob, J Weitz, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Comparison Of Apixaban, Dabigatran, Rivaroxaban, And Edoxaban In The Acute Treatment And Prevention Of Venous Thromboembolism: Systematic Review And Network Meta-Analysis</a><div class="gs_gray">AT Cohen, S Batson, M Hamilton, C Masseria, S Mitchell, H Phatak</div><div class="gs_gray">Value in Health 18 (3), A132<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">COMPARISON OF ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY FOR THE EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS</a><div class="gs_gray">A Cohen, S Batson, M Hamilton, C Masseria, S Mitchell, H Phatak</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A2086-A2086<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Impact of Thromboprophylaxis</a><div class="gs_gray">W Huang, FA Anderson, SK Rushton-Smith, AT Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Continuing Medical Education Activity in Academic Emergency Medicine</a><div class="gs_gray">P Prandoni, MH Prins, AT Cohen, K Müller, ÁF Pap, MC Tewes, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Clinical Events Avoided With Apixaban Compared to Current Standard of Care for the Initial and Extended Treatment and Prevention of Venous Thromboembolism</a><div class="gs_gray">T Lanitis, M Hamilton, D Rublee, R Leipold, C Browne, P Quon, A Cohen</div><div class="gs_gray">Circulation 130 (suppl_2), A18404-A18404<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Logistics of Monitoring of Vitamin K Antagonists in Western European Countries: Prefer in Vte Registry</a><div class="gs_gray">M Monreal, R Bauersachs, AK Gitt, P Laeis, P Mismetti, SN Willich, ...</div><div class="gs_gray">Value in Health 17 (7), A504<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Lifetime Clinical Events Avoided And Resource Utilization With Apixaban Compared To Low-Molecular-Weight Heparin Followed By A Vitamin K Antagonist For The Treatment And&nbsp;…</a><div class="gs_gray">M Hamilton, H Phatak, T Lanitis, J Mardekian, DA Rublee, R Leipold, ...</div><div class="gs_gray">Value in Health 17 (7), A475<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy</a><div class="gs_gray">S Granziera, AT Cohen</div><div class="gs_gray">BMJ Evidence-Based Medicine 19 (5), 180-180<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Venous thromboembolism management in European countries: Baseline characteristics, risk factors, and comorbidity data from the PREFER in VTE Registry</a><div class="gs_gray">AT Cohen, R Bauersachs, AK Gitt, P Laeis, P Mismetti, M Monreal, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 1063-1064<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Oral Rivaroxaban Versus Standard Therapy for the Treatment of Symptomatic Venous Thromboembolism in Patients with Cancer</a><div class="gs_gray">MH Prins, T Lensing, P Prandoni, AT Cohen, B Davidson, F Misselwitz, ...</div><div class="gs_gray">Annals of Oncology 25, v1<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Predictors of hospitalization during extended treatment of venous thromboembolism in the AMPLIFY-EXT trial</a><div class="gs_gray">X Liu, M Johnson, J Mardekian, J Thompson, H Phatak, M Hamilton, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 9-10<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Og1tA8FjbJAC" class="gsc_a_at">Time course of recurrent venous thromboembolic and major bleeding events during anticoagulant therapy with apixaban or enoxaparin/warfarin: analysis of the amplify data using&nbsp;…</a><div class="gs_gray">G Raskob, A Gallus, G Agnelli, H Buller, A Cohen, S Chaudhuri, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 12<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">ALICAT: Anticoagulation length in cancer associated thrombosis-a mixed-methods feasibility study</a><div class="gs_gray">S Noble, JD Smith, J Baillie, T Baglin, GO Griffiths, A Casbard, D Cohen, ...</div><div class="gs_gray">Thrombosis Research 133 (Supp 2), S220-S220<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:2l5NCbZemmgC" class="gsc_a_at">C0473: Prevention of Thromboembolic Events? European Registry in Venous Thromboembolism-Design of the Prefer in VTE</a><div class="gs_gray">A Cohen, R Bauersachs, A Gitt, P Laeis, P Mismetti, M Monreal, S Willich, ...</div><div class="gs_gray">Thrombosis Research, S122<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kF1pexMAQbMC" class="gsc_a_at">Achim, N. P3. 4 Brodmann, M. FV5. 3 Erbel, R. FV7. 3</a><div class="gs_gray">G Agnelli, C Espinola-Klein, B Amann, B Amend, V Buciuceanu, ...</div><div class="gs_gray">Vasa 43, 86<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Erratum a&gt;[Ann. Fr. Anesth. Reanim. 2013; 32: 691-700]</a><div class="gs_gray">G Pernod, P Albaladejo, A Godier, CM Samama, S Susen, Y Gruel, ...</div><div class="gs_gray">ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION 33 (3), 198-199<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">C0472: Trends in Medical Management of Patients with VTE in 7 European Countries: First Baseline Data of the Prefer in VTE Registry</a><div class="gs_gray">G Agnelli, R Bauersachs, A Gitt, P Mismetti, M Monreal, S Willich, P Laeis, ...</div><div class="gs_gray">Thrombosis Research, S121-S122<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Anticoagulation length in cancer associated thrombosis: a mixed-methods feasibility study</a><div class="gs_gray">SIR Noble, J Baillie, J Smith, T Baglin, G Griffiths, AC Casbard, D Cohen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Risk factors for recurrent venous thromboembolism: VTE Epidemiology Group (VEG) Study: OC 63.4</a><div class="gs_gray">C Martinez, A Katholing, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BOlwja0KXvYC" class="gsc_a_at">Risk factors for severe post-thrombotic syndrome: VTE Epidemiology Group (VEG) Study: AS 06.3</a><div class="gs_gray">A Cohen, C Martinez, A Katholing</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Apixaban is equally effective as conventional treatment for treatment of acute VTE</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray">N Engl J Med<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Determinants for anticoagulant use in patients with first-time venous thromboembolism: VTE Epidemiology Group (VEG) Study</a><div class="gs_gray">C Martinez, A Cohen, S Rietbrock</div><div class="gs_gray">JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 469-469<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Risk factors for chronic pulmonary hypertension: VTE Epidemiology Group (VEG) Study: AS 19.1</a><div class="gs_gray">A Cohen, C Martinez, S Rietbrock</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Mortality following Venous thromboembolism. Risk factors from a large cohort. VTE Epidemiology Group (VEG) Study: OC 63.5</a><div class="gs_gray">A Cohen, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11, 226-227<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Apixaban is even effectief als conventionele therapie voor behandeling van acute VTE</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray">N Engl J Med<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Rivaroxaban of no net clinical benefit in critically ill patients</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Reactions 1441, 2<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">The design and rationale for the APEX study (Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban)</a><div class="gs_gray">AT Cohen, MD Robert Harrington, SZ Goldhaber, MD Russell Hull, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy</a><div class="gs_gray">JH Zong, L Eckert, L Zhang, WS Dai, GH Lyman, AT Cohen</div><div class="gs_gray">Value in Health 15 (7), A434-A435<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Long-term benefits of preventing venous thromboembolic events (vol 28, pg 877, 2012)</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">CURRENT MEDICAL RESEARCH AND OPINION 28 (9), 1574-1574<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Oncology and public health</a><div class="gs_gray">JH Zong, L Eckert, L Zhang, WS Dai, AT Cohen, GH Lyman</div><div class="gs_gray">Annals of Oncology 23 (suppl_9)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Risk factors for venous thromboembolism (VTE) in medical patients in the VTE epidemiology group (VEG) study: O-TH-089</a><div class="gs_gray">A Cohen, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Venous thromboembolism (VTE): disease burden and outcomes-VTE epidemiology group (VEG) study: O-TH-087</a><div class="gs_gray">C Martinez, S Rietbrock, L Bamber, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Incidence of venous thromboembolism (VTE) in the medically-ill population-vte epidemiology group (VEG) study: O-MO-096</a><div class="gs_gray">A Cohen, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Social risk factors for venous thromboembolism (VTE) in the VTE epidemiology group (VEG) study: O-TH-139</a><div class="gs_gray">A Cohen, S Rietbrock, C Martinez</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Comparative effectiveness of thromboprophylaxis in acutely ill medical patients across the US acute hospital setting: O-TH-086</a><div class="gs_gray">W Huang, F Anderson, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: analysis of factors contributing to benefit and risk in MAGELLAN: P&nbsp;…</a><div class="gs_gray">A Cohen, T Spiro, H Buller, L Haskell, D Hu, R Hull, A Mebazaa, G Merli, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Risk factors for venous thromboembolism (VTE) in surgical patients in the VTE epidemiology group (VEG) study: O-TH-088</a><div class="gs_gray">C Martinez, S Rietbrock, A Cohen</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9, 749-750<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Effectiveness of prophylactic treatment in preventing thromboembolic events in medical subgroups: A meta-analysis of randomised clinical trials: 12</a><div class="gs_gray">E Davis, A Cohen</div><div class="gs_gray">British Journal of Haematology 149, 5-6<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Impact of age, body mass index, and renal impairment on venous thromboembolism risk and prophylaxis practices in the acute hospital care setting: a subanalysis of the endorse&nbsp;…</a><div class="gs_gray">F Anderson, A Cohen, V Tapson, J Bergmann, S Goldhaber, A Kakkar</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 7<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Evaluation of the risk and prophylaxis of venous thrombo-embolic events in medical hospitalised patients: résults in France of the international survey endorse: 559</a><div class="gs_gray">J Bergmann, A Cohen, V Tapson, A Kakkar, S Goldhaber, M Behar, ...</div><div class="gs_gray">Fundamental and Clinical Pharmacology 23<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Idraparinux versus standard therapy in the treatment of deep vein thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial</a><div class="gs_gray">FF van Doormaal, AT Cohen, BL Davidson, AS Gallus, M Gent, F Piovella, ...</div><div class="gs_gray">Venous thromboembolism, coagulation and cancer, 107<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">The Unmet Need for Extended Thromboprophylaxis in Acutely III Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM</a><div class="gs_gray">FA Anderson Jr, RD Hull, SM Schellong, B Deslandes, VF Tapson, ...</div><div class="gs_gray">BLOOD 112 (11), 692-692<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Impact of Surgery Type and Co-Morbidities on Venous Thromboembolism prophylaxis Practices in Patients Undergoing Major Surgical Procedures in Acute Care Hospitals Worldwide: A&nbsp;…</a><div class="gs_gray">AK Kakkar, AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 171-171<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.</a><div class="gs_gray">FA Anderson Jr, RD Hull, SM Schellong, B Deslandes, VF Tapson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 1981-1981<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:f2IySw72cVMC" class="gsc_a_at">Thromboprophylaxis for patients at high risk of VTE–Authors' reply</a><div class="gs_gray">AT Cohen, VF Tapson, FA Anderson</div><div class="gs_gray">The Lancet 371 (9628), 1912-1913<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Venous Thromboembolic Risk and Suboptimal Prophylaxis in the US Acute Hospital Care Setting: Findings from the ENDORSE Study.</a><div class="gs_gray">VF Tapson, AT Cohen, JF Bergmann, S Goldhaber, AK Kakkar, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1858-1858<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Overview of Current Trends and the Future of Thromboprophylaxis in Orthopaedic Surgery</a><div class="gs_gray">F Tudor, C Hee, A Singh, K Akinola, AT Cohen</div><div class="gs_gray">Vascular Disease Prevention 4 (2), 171-175<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Blood Coagulation, Fibrinolysis and Cellular Haemostasis-Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality</a><div class="gs_gray">AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ...</div><div class="gs_gray">Bulk Solids Handling 27 (6), 756-764<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">THROMBOELASTOGRAPHIC CHANGES FOLLOWING AUTOLOGOUS TRANSFUSION IN PRIMARY TOTAL KNEE REPLACEMENT</a><div class="gs_gray">W Bartlett, C Lee, RWJ Carrington, AT Cohen, JA Skinner</div><div class="gs_gray">Orthopaedic Proceedings 88 (SUPP_II), 254-255<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RtRctb2lSbAC" class="gsc_a_at">Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92&nbsp;…</a><div class="gs_gray">A Cohen, C Hirst, B Sherrill, P Holmes, D Fidan</div><div class="gs_gray">British Journal of Surgery 93 (3), 375-376<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Letter 3: Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg&nbsp;…</a><div class="gs_gray">G Agnelli, D Bergqvist, O Dahl, B Eriksson, M Rud Lassen, P Mouret, ...</div><div class="gs_gray">Journal of British Surgery 93 (3), 375-375<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:naSTrk-c4S8C" class="gsc_a_at">illness, infection or inflammatory disorders** This study was supported by Sanofi-Synthelabo and NV Organon.</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Inpharma 1523, 4<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Contents Vol. 35, 2006</a><div class="gs_gray">M Colafranceschi, M Papi, A Giuliani, G Amiconi, A Colosimo, OE Dahl, ...</div><div class="gs_gray">Pathophysiology of Haemostasis and Thrombosis 35 (6), 459-460<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Author Index Vol. 35, 2006</a><div class="gs_gray">M Colafranceschi, M Papi, A Giuliani, G Amiconi, A Colosimo, OE Dahl, ...</div><div class="gs_gray">Pathophysiology of Haemostasis and Thrombosis 35 (6), 457-457<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Thromboprophylaxis in Medical Patients: An Update</a><div class="gs_gray">SA Singh, F Tudor, C Hee, AT Cohen</div><div class="gs_gray">Vascular Disease Prevention 3 (1), 19-25<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Subject Index Vol. 35, 2006</a><div class="gs_gray">M Colafranceschi, M Papi, A Giuliani, G Amiconi, A Colosimo, OE Dahl, ...</div><div class="gs_gray">Pathophysiology of Haemostasis and Thrombosis 35 (6), 458-458<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">PCV18 WHEN SHOULD PATIENTS BE SWITCHED FROMVKATO NEW TREATMENT: DEVELOPMENT AND PILOT TESTING OF A SELF-REPORTED QUESTIONNAIRE TO TARGET PATIENTS WHO WOULD BENEFIT MOST</a><div class="gs_gray">B Arnould, K Benmedjahed, MC Alessi, A Cohen, M Guenoun, P Mismetti, ...</div><div class="gs_gray">Value in Health 8 (6), A94<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">PCV87 VITAE THROMBOSIS STUDY: THE PREVALENCE AND BURDEN OF VENOUS THROMBOEMBOLIC DISEASE (VTE) IN EUROPE</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">Value in Health 6 (8), A115<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.</a><div class="gs_gray">AT Cohen, R Alikhan, JI Arcelus, JF Bergmann, S Haas, GJ Merli, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1786-1786<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Fatal Pulmonary Embolism and Cancer-a Post Mortem Study.</a><div class="gs_gray">AT Cohen, GJ Weston, AJ Tasker, GA Fellows, R Wilmott</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 2593-2593<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis.</a><div class="gs_gray">AT Cohen, AS Gallus, BL Davidson, MR Lassen, MH Prins, W Tomkowski, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 4079-4079<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">O1065 XIMELAGATRAN, AND ITS SUBCUTANEOUS FORM MELAGATRAN, VS. ENOXAPARIN AS THROMBOPROPHYLAXIS IN TOTAL HIP OR TOTAL KNEE REPLACEMENT</a><div class="gs_gray">BI Eriksson, G Agnelli, AT Cohen, OE Dahl, MR Lassen, P Mouret, ...</div><div class="gs_gray">Orthopaedic Proceedings 86 (SUPP_III), 232-233<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:O0nohqN1r9EC" class="gsc_a_at">ORIGINAL INVESTIGATIONS-Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness: Analysis of the MEDENOX Study</a><div class="gs_gray">R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...</div><div class="gs_gray">Archives of Internal Medicine 164 (9), 963-968<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">XIMELAGATRAN, AND ITS SUBCUTANEOUS FORM MELAGATRAN, VS. ENOXAPARIN AS THROMBOPROPHYLAXIS IN TOTAL HIP OR TOTAL KNEE REPLACEMENT</a><div class="gs_gray">B Eriksson, G Agnelli, A Cohen, O Dahl, M Lassen, P Mouret, ...</div><div class="gs_gray">The Journal of Bone and Joint Surgery-british Volume 86, 232-233<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">FIXED DOSE ORAL XIMELAGATRAN IS EFFICACIOUS AND WELL TOLERATED AS THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT OR TOTAL KNEE REPLACEMENT</a><div class="gs_gray">AT Cohen, BI Eriksson, G Agnelli, OE Dahl, P Mouret, N Rosencher</div><div class="gs_gray">Orthopaedic Proceedings 85 (SUPP_II), 180-180<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Langstreckenfluge und TVT: Signifikantes Risiko nur, wenn weitere Risikofaktoren vorliegen</a><div class="gs_gray">R Arya, JA Barnes, U Hossain, RK Patel, AT Cohen</div><div class="gs_gray">VASOMED-BONN- 15 (3), 105-105<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Blood Coagulation, Fibrinolysis and Cellular Haemostasis-Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of&nbsp;…</a><div class="gs_gray">BI Eriksson, G Agnelli, AT Cohen, OE Dahl, P Mouret, N Rosencher, ...</div><div class="gs_gray">Thrombosis and Haemostasis 89 (2), 288-296<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Reply to Rosendaal <i>et al</i></a><div class="gs_gray">R Arya, AT Cohen</div><div class="gs_gray">British Journal of Haematology 120 (2), 368-368<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Epidemiology of fatal pulmonary embolism in surgical patients</a><div class="gs_gray">F Peters, R Alikhan, P Pettit, H Zaw, A Cohen, A Pagliuca</div><div class="gs_gray">BLOOD 100 (11), 116B-116B<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Longer is better for thromboembolism prophylaxis after cancer surgery</a><div class="gs_gray">D Bergqvist, G Agnelli, AT Cohen</div><div class="gs_gray">Formulary 37 (5), 230<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Thromboprohylaxis in general medical patients: low molecular weight heparin versus unfractionated heparin</a><div class="gs_gray">R Alikhan, I Osborne, R Wilmott, P Vaughan, C Lomas, A Cohen</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:wLxue7F8ec0C" class="gsc_a_at">Rigg JRA, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW et al. for the MASTER Anaesthesia Trial Study Group. Epidural anaesthesia and analgesia and outcome of major&nbsp;…</a><div class="gs_gray">D Bergqvist, G Agnelli, AT Cohen, A Eldor, PE Nilsson, L NystroÈm, ...</div><div class="gs_gray">N Engl J Med 346, 975-80<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:gsN89kCJA0AC" class="gsc_a_at">General Papers 17</a><div class="gs_gray">R Al‐Ghnaniem, R Alikhan, HM Zaw, C Keers, DJ Cooper, AG Patel, ...</div><div class="gs_gray">British Journal of Surgery 89 (S1), 19-19<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Improving outcomes in hip-fracture surgery</a><div class="gs_gray">A Cohen, H Zaw, I Osborne</div><div class="gs_gray">GERIATRIC MEDICINE-LONDON THEN SEVENOAKS- 32 (10), 35-44<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:rO6llkc54NcC" class="gsc_a_at">Diagnosis of pulmonary embolism: Positive predictive value of clinical assessment prior to implementation of a pre-test probability algorithm.</a><div class="gs_gray">P Vaughan, R Alikhan, C Keers, J Messenger, J Gardner, AT Cohen</div><div class="gs_gray">BLOOD 98 (11), 101B-101B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:evX43VCCuoAC" class="gsc_a_at">PCV18: COST EFFECTIVENESS OF ENOXAPARIN VS. UNFRACTIONATED HEPARIN FOR THE PROPHYLAXIS OF DVT AND SUBSEQUENT LONG-TERM COMPLICATIONS IN TOTAL HIP REPLACEMENT SURGERY IN THE&nbsp;…</a><div class="gs_gray">M Botteman, AT Cohen, V Nadipelli, J Stephens, CL Pashos, J Caprini</div><div class="gs_gray">Value in Health 4 (6), 495<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4DMP91E08xMC" class="gsc_a_at">A targeted approach to thrombosis: New data, new perspectives-Conclusion</a><div class="gs_gray">BL Davidson, AT Cohen</div><div class="gs_gray">SEMINARS IN HEMATOLOGY 38 (2), 75-77<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">A targeted approach to thrombosis: New data, new perspectives—Introduction</a><div class="gs_gray">BL Davidson, AT Cohen</div><div class="gs_gray">Seminars in Hematology, 1-3<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Anatomical reduction of intra-articular fractures of the distal radius</a><div class="gs_gray">R ALIKHAN, AT COHEN</div><div class="gs_gray">J Bone Joint Surg [Br] 2001 (83-B), 460-3<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">The efficacy and safety of prolonged one month enoxaparin thromboprophylaxis for elective abdominal cancer surgery: The Enoxacan II study.</a><div class="gs_gray">D Berqvist, G Agnelli, A Cohen, A Eldor, P Nilsson</div><div class="gs_gray">BLOOD 96 (11), 654A-654A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:L_l9e5I586QC" class="gsc_a_at">Enoxaparin for the Prevention of Venous Thromboembolism</a><div class="gs_gray">MM Samama, AT Cohen, A Leizorovicz</div><div class="gs_gray">The New England Journal of Medicine 342 (2)<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Thromboprophylaxis of venous thromboembolism in acutely ill medical patients with enoxaparin-Consistency of treatment effect across disease groups: The MEDENOX trial.</a><div class="gs_gray">A Cohen</div><div class="gs_gray">BLOOD 94 (10), 103B-103B<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Mortality reduction with low molecular weight heparin thromboprophylaxis in acutely ill medical patients: The MEDENOX trial.</a><div class="gs_gray">L Desjardins, AT Cohen, A Eldor, C Janbon, CG Olsson, MM Samama, ...</div><div class="gs_gray">BLOOD 94 (10), 31A-31A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Prophylaxis of venous thromboembolism in acute medical patients with enoxaparin: An international, randomized double-blind, placebo-controlled trial</a><div class="gs_gray">AGG Turpie, MM Samama, AT Cohen, JY Darmon, RP Rorer, ...</div><div class="gs_gray">CIRCULATION 100 (18), 619-619<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">TPE2: ECONOMIC EVALUATION OF ENOXAPARIN AS POST DISCHARGE PROPHYLAXIS FOR DEEP VEIN THROMBOSIS (DVT) IN ELECTIVE HIP SURGERY</a><div class="gs_gray">LM Davies, GA Richardson, AT Cohen</div><div class="gs_gray">Value in Health 5 (2), 375<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis</a><div class="gs_gray">AT Cohen, AS Gallus, S Haas, M Monreal, M Pini</div><div class="gs_gray">Blood coagulation &amp; fibrinolysis 10, S99-S102<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:sfnaS5RM6jYC" class="gsc_a_at"># 612 Attitudes about participation in a randomized trial of alternate initial treatments of childhood idiopathic thrombocytopenic purpura (ITP): results of a survey of members&nbsp;…</a><div class="gs_gray">GR Buchanan, S Vesely, G Raskob, A Cohen, J George</div><div class="gs_gray">Journal of Pediatric Hematology/Oncology 20 (4), 376<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Prospective Surveillance for Perioperative Venous Thrombosis</a><div class="gs_gray">V Sharma, J Howes, AT Cohen</div><div class="gs_gray">Archives of Surgery 132 (2), 212-212<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:0izLItjtcgwC" class="gsc_a_at">The Efficacy and Safety of Heparin Thromboprophylaxis in General Surgery</a><div class="gs_gray">AT Cohen</div><div class="gs_gray">University of Melbourne, Department of Medicine, Dentistry and Health Sciences<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Discussion-Patients at risk of venous thromboembolism--Clinical results with reviparin</a><div class="gs_gray">VV Kakkar, AT Cohen, MS Mohamed</div><div class="gs_gray">Thrombosis Research-Supplements, S45<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:27LrP4qxOz0C" class="gsc_a_at">RISK-FACTORS FOR FEMOROPOPLITEAL BYPASS GRAFT OCCLUSION FOLLOWING RECONSTRUCTIVE SURGERY</a><div class="gs_gray">AT COHEN, MB WAGNER, DJ GARRARD, SK DAS, VV KAKKAR</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 73 (6), 1384-1384<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">LOW-MOLECULAR-WEIGHT HEPARIN VERSUS ASPIRIN AND DIPYRIDAMOLE AFTER FEMOROPOPLITEAL BYPASS-GRAFTING-REPLY</a><div class="gs_gray">VV KAKKAR, RA EDMONDSON, AT COHEN</div><div class="gs_gray">LANCET 344 (8936), 1571-1572<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">RISK-FACTORS FOR PERIOPERATIVE BLEEDING IN PATIENTS RECEIVING HEPARIN-PROPHYLAXIS</a><div class="gs_gray">AT COHEN, MB WAGNER, MS MOHAMED, RA EDMONDSON, ...</div><div class="gs_gray">BRITISH JOURNAL OF SURGERY 81 (12), 1805-1805<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">The causes and management of pulmonary embolism</a><div class="gs_gray">R Edmonson, A Cohen</div><div class="gs_gray">CARE OF THE CRITICALLY ILL 10, 26-26<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:8xutWZnSdmoC" class="gsc_a_at">DOES THE BLEEDING INDUCED BY HEPARIN-PROPHYLAXIS SIGNIFICANTLY ALTER THE OUTCOME OF SURGERY</a><div class="gs_gray">VV KAKKAR, MJ PHILLIPS, AT COHEN, RA EDMONDSON, SK DAS, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 650-650<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:geHnlv5EZngC" class="gsc_a_at">AN EVALUATION OF THE EFFECTS OF A SINGLE-DOSE OF PROSTAGLANDIN-E (1) ON FIBRINOLYTIC-ACTIVITY DURING MAJOR SURGERY</a><div class="gs_gray">D WEITZEL, MJ PHILLIPS, RA EDMONDSON, AT COHEN, E MELISSARI, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 1265-1265<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">THROMBIN INHIBITOR (HIRULOG (TM)) IN THE TREATMENT OF CALF VEIN-THROMBOSIS</a><div class="gs_gray">RA EDMONDSON, AT COHEN, MJ PHILLIPS, E MELISSARI, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 1301-1301<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:BqipwSGYUEgC" class="gsc_a_at">HOW LONG SHOULD PROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) BE CONTINUED</a><div class="gs_gray">VV KAKKAR, AT COHEN, MJ PHILLIPS, RA EDMONDSON, DJ COOPER, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 69 (6), 648-648<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:FsLZdJ3BAzkC" class="gsc_a_at">PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ABDOMINAL-SURGERY-REPLY</a><div class="gs_gray">VV KAKKAR, AT COHEN, RA EDMONSON, SK DAS, DJ COOPER</div><div class="gs_gray">Lancet 341 (8848), 824-824<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:lvd772isFD0C" class="gsc_a_at">Deep venous thrombosis and thromboembolism</a><div class="gs_gray">RA Edmondson, AT Cohen, VV Kakkar</div><div class="gs_gray">Saudi medical journal 14 (5), 391-397<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Analyse brève Apixaban pour prolonger un traitement préventif secondaire d’une thromboembolie veineuse?</a><div class="gs_gray">G Agnelli, H Buller, A Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">BRITISH MEDICAL JOURNAL NO 6796 VOLUME 303 CLINICAL RESEARCH</a><div class="gs_gray">R Jackson, R Scragg, R Beaglehole, M Makela, M Heliovaara, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">How To Manage Patients With Venous Thromboembolism CME</a><div class="gs_gray">AT Cohen, AGG Turpie</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">CONSENSO VENEZOLANO DE ENFERMEDAD TROIVIBOEMBÓLICA VENOSA</a><div class="gs_gray">AT Cohen, HM Zaw</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:nZcligLrVowC" class="gsc_a_at">Bondige bespreking Secundaire preventie van veneuze trombo-embolie: langetermijnbehandeling met apixaban?</a><div class="gs_gray">G Agnelli, H Buller, A Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Getting Smart About Secondary Prevention of VTE: Practical Strategies for the Use of New Therapies CME</a><div class="gs_gray">AT Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Tijdschrift voor Evidence-Based Medicine</a><div class="gs_gray">G Agnelli, HR Buller, A Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Asymptomatic proximal DVT, symptomatic proximal or distal DVT, symptomatic PE (nonfatal), or VTE mortality at first 10 days 2.7% vs. 2.7%(RR 0.97; 95% CI 0.71-1.31; P= 0.003&nbsp;…</a><div class="gs_gray">AT Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:foquWX3nUaYC" class="gsc_a_at">Guidelines on the use and monitoring of heparin</a><div class="gs_gray">T Baglin, TW Barrowcliffe, A Cohen, M Greaves</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Dalteparin Reduced Venous Thromboembolic Events Without Increased Bleeding in Acutely Ill Medical Patients/COMMENTARY</a><div class="gs_gray">A Leizorovicz, AT Cohen, AG Turpie</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:XiSMed-E-HIC" class="gsc_a_at">VTE (composite of asymptomatic proximal DVT, symptomatic proximal or distal DVT, symptomatic nonfatal PE, or VTE-related death) Cohort</a><div class="gs_gray">AT Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:SP6oXDckpogC" class="gsc_a_at">Bondige bespreking Geen rivaroxaban voor patiënten met verminderde mobiliteit door een interne pathologie</a><div class="gs_gray">AT Cohen, TE Spiro, HR Büller</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Predicting the Risk of Venous Thromboembolism in Patients Hospitalized with Heart Failure</a><div class="gs_gray">AT Cohen</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:dhFuZR0502QC" class="gsc_a_at">Analyse brève Pas de rivaroxaban pour les patients immobilisés pour une pathologie médicale</a><div class="gs_gray">AT Cohen, TE Spiro, HR Büller</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=YtROf4UAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=YtROf4UAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Tijdschrift voor Evidence-Based Medicine</a><div class="gs_gray">MM SAMAMA, AT COHEN, J DARMON</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–599</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>